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Abstract
Transformations on a cellular level caused by changes in gene expression, pro-
tein abundance, or epigenetic features present in cells play a key role in di↵erentiation,
reprogramming and disease. Such transformations are frequently stochastic on a single-
cell level. The result is a heterogeneous cell population with an ever-changing mixture.
Often cells undergo transformation via intermediate stages, which further convolute the
transformation process. Reliable high-throughput data is commonly obtained on a cell
population level therefore elucidating the underlying single-cell process is challenging.
In this thesis we present and analyse models that probe population level data to answer
questions about the transformation process and to distinguish between states.
We investigate a recently proposed stochastic model for transition processes called
STAMM, which is based on a latent Markov chain at the single-cell level. We present a
computationally e cient unbiased approach to estimation, model selection and setting
of tuning parameters. To complement our understanding of properties and behaviour of
the model we implement a single-cell simulation setup. This not only allows us to inves-
tigate parameter estimation but we can also explore behaviour under violations of model
assumptions. We also empirically investigate identifiability of the model. We apply the
model to oncogenic transformation where the data time-course consists of genome-wide
RNA-seq measurements. We also compare results from application of STAMM to a
stem cell reprogramming microarray time-course to single-cell measurements carried out
independently. Results show that not only is the model robust under mild violations
of assumptions but state specific results can be compared to single-cell measurements.
Under stronger violation of assumptions transitions between states are not estimated
well. The model is therefore especially useful to steer further experiments in the right
direction.
We then present a model that examines the response of cells in the cell cycle to
incident radiation at di↵erent doses. Cells can either undergo programmed cell death
or re-enter the cell cycle after an interruption. A genome-wide RNA-seq measurement
is made at the initial time point and subsequently fractions of cells with contrasting
cell-fates can be distinguished and counted. The model assigns a score to each gene
corresponding to its importance in determining cell fate. We implement a single-cell
level simulation procedure and carry out illustrative simulations for one gene and for
four genes. Parameter estimation in this model allows distinguishing genes that are
important from genes that are not. This is only possible as long as the noise level is not
too high.
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Chapter 1
Introduction
Biological systems have been studied for centuries, motivated by both fundamental ques-
tions concerning living systems, and by medical applications. Mathematical and physical
principles have long been understood to underpin biological phenomena [Lotka, 1925;
Rashevsky, 1935]. In recent years, widespread use of mathematical, computational and
physical approaches for biological investigation has gathered pace, partly due to tech-
nological advances that permit quantitative study of biomolecular systems. Moreover,
computational advances allow for more e cient modelling and simulation of such sys-
tems. Possibly one of the most successful application of mathematical and physical ideas
to a biological problem can be found in neuroscience, starting from basic principles of
current flow in axons to the propagation of action potentials in neurons first studied in
a squid axon by Hodgkin & Huxley [1952]. After this remarkable breakthrough, further
development in the field included increased involvement of mathematical ideas. A num-
ber of advancements have been made which would have been unthinkable without the
influence of mathematics in the field [Amari, 2013].
The last two decades have seen an increase in the availability of high through-
put data driven by technological advancements and the decrease in cost [Schadt et al.,
2010]. This in turn has lead to the increased need of mathematical techniques to fully
understand phenomena underlying observed data. Simply observing and analysing the
abundant data available is not an e↵ective method, as even measuring a single sam-
ple can include data with thousands of components and comparing them manually is
unreasonable. Additionally it has been determined that an approach of studying each
component of the system independently is not su cient for detailed understanding. The
cell contains many regulatory components most important are genes and proteins. In-
teractions exist between components of the same type as well as between components
1
of di↵erent types. This leads to a tremendous number of interactions that needs to be
understood, increasing the need for an approach including biological experiments as well
as expertise in mathematics, statistics, physics and engineering.
In physics, the use of mathematics alongside experiments has allowed for a more
profound understanding of physical phenomena. As an example, classical mechanics
allows a relatively simple description of macro phenomena, even though we know that
some of the assumptions do not always hold we can still make accurate predictions.
On the other hand, we have the description of micro phenomena described by quantum
mechanics. However, even though it is possible to describe macro phenomena using
quantum mechanics there is no need to include that detail. Analogous to physics, in
biology intracellular and intercellular interactions that lead to disease can be deduced
without a full understanding of all the elements involved in its description. Approaching
this problem from the other direction, it is possible to study interactions of simple genes
and proteins, as these interactions are not yet fully understood. It is therefore not
possible to say if such an approach will eventually allow the description of cell level
behaviour. Unlike physics, in biological systems there is still work needed for both
approaches.
An extremely important process universal in many areas of biology is the trans-
formation of cells from one type to another: cell di↵erentiation [Tang et al., 2010; Vier-
buchen et al., 2010], stem cell reprogramming [Takahashi & Yamanaka, 2006; Hanna
et al., 2010], and disease formation [Hanahan & Weinberg, 2000; Vogel, 2010] to name
but a few. These changes can be on the genetic level, on a protein level, or even on an
epigenetic1 level. The transitions can be driven or initiated by very small perturbations
in the form of induced genes. For such a system single-cell stochasticity is a very power-
ful concept and has been observed in a variety of experimental settings, such as E. coli
[Elowitz et al., 2002] and stem cell reprogramming [Hanna et al., 2009]. Since stochastic
transitions, occur on a single-cell level, at any time during a transition the cell popula-
tion as a whole exists in a mixture of states. Moreover, the exact composition of this
mixture changes over time. Any measurements performed on homogenates2 from this
population results in population averages with unknown composition. Trivially the best
strategy would be to measure at the single-cell level. Despite advancements in genome-
wide single-cell measurements [de Souza, 2012; Tang et al., 2011] there remain challenges
including limited availability of such data and limits to the number of genes that can be
measured. Furthermore, such measurements do not allow live tracking of cells and in fact
1see Section 2.2.1 for a more detailed discussion on epigenetics
2mixture obtained from mechanically broken down cells
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the measurement process itself destroys cells thereby breaking continuity (i.e. the next
measurement is on a di↵erent set of cells). These are the reasons for an incomplete un-
derstanding of transition processes. Therefore understanding transformation processes
from aggregated data is important.
Inevitably, an important question arises here about our definition of states in
the transformation. There are many ways to approach this and an obvious way is to
define states in a biological sense, but there is no consensus on a biologically motivated
definition of a state. In a biological sense a complete definition of a state would include
all possible information regarding the state, if we don’t include the di↵erent stages of
the cell cycle as distinct states we have to define an area in this complex space as some
changes in the cell will be due to inherent noise or the cell cycle. In most cases, not all
information is available or is limited due to cost. In this work when we talk about states,
we are referring to changes in gene expression to a number of genes across the genome.
The study of stem cell reprogramming plays an important role in the development
of personalised medicine, which in its extreme would allow the regrowth of whole organs
to replace damaged ones. This could circumvent any issues arising from treatments
derived using foreign cells, as treatments would originate from the patients own cells.
Work carried out in this field has yielded the development of techniques that allow the
development of neurons from embryonic stem cells [Vierbuchen et al., 2010; Pang et al.,
2011] or creating muscle cells [Ieda et al., 2010; Efe et al., 2011]. These processes could
become even more powerful when the starting point is a di↵erentiated cell harvested
from the patient [Takahashi & Yamanaka, 2006]. There are still unanswered questions
in this field about the di↵erences of cells derived from di↵erentiated cells to cells derived
directly from embryonic stem cells [Carey et al., 2011; Bock et al., 2011]. A better
understanding of the transformation process would help in identifying issues and could
propose potential ways of improving the transformation process.
Cancer is a disease so prevalent in modern society that in the UK the lifetime
chance of contracting cancer is more than one in three [Sasieni et al., 2011]. The disease
has its source in multiple genetic mutations causing changes to natural cell functions
such as cell proliferation and apoptosis3, which transforms cells from a healthy state to
a cancerous state. These mutations code for proteins that are implicated in the eight
hallmarks of cancer [Hanahan & Weinberg, 2011]. The hallmarks are the circumvention
for the need of external growth signals; cells are una↵ected by external growth-inhibition
signals; evasion of apoptosis; unlimited replication; the potential to create additional
blood vessels from existing ones; invasion of other tissue types; energy management of the
3programmed cell-death
3
cell and avoiding the bodies immune response. Understanding the transformation process
that changes a healthy cell population to a cancerous one would allow intervention target
at specific genes and proteins.
The cell cycle is central to the proliferation of cells and hence plays a key role in
both transformations mentioned above. In fact mutations that can lead to cancer can be
acquired during the cell cycle as this is the process during which DNA is replicated and
the replication process can at times lead to errors. In a normal cell there are multiple
checks that prevent such errors from propagating, but in an unhealthy cell genes central
to these processes are mutated leading to malfunctions. Radiation plays an important
role in the cell as it can be a cause of mutations and is also used as treatment to kill
unhealthy cells; damage to DNA can lead to apoptosis during the cell cycle. Radiation
e↵ects on the cell include changes in gene expression and are also related to radiation
strength [Gentile et al., 2003]. Some cells will arrest in the cell cycle after radiation
damage either leading to apoptosis or a brief pause in the cell cycle followed by a re-
entry to the cell cycle [Pawlik & Keyomarsi, 2004]. Understanding the mechanism that
leads to the di↵erent responses is key in treatment as well as prevention of cancer.
In this thesis we attempt to learn single-cell level information from homogenate
population averaged data of various types. We especially focus on gene expression and
the role of genes in transformation. We take a data driven approach where model pa-
rameters are estimated by comparison to data. The first model we use is based on latent
Markov processes aggregated over cells using a least squares estimation; it takes inspi-
ration from the success in application of latent variable models such as hidden Markov
models (HMMs) to hidden transitions in biology and genomics [Yoon, 2009; Ernst &
Kellis, 2012]. The second model uses simple statistical principles for the derivation of
the model and Monte Carlo integration to approximate an integral. These are simple
models that allow investigation of complicated biological processes.
HMM’s have been successfully applied to study a variety of biological phenomena
such as gene prediction, sequence alignment and RNA folding among many others [Yoon,
2009, and references therein]. One of the most successful applications in recent times
has been ChromeHMM [Ernst & Kellis, 2012].4 The model is focused on understanding
epigenetic modification and their e↵ect on gene expression. As we know DNA encodes
genes, but epigenetic modifications enable interpretation of the information contained on
DNA. It is responsible for huge diversity found in cells across the human body. Histones
are proteins found in cells that order and package DNA and more than 100 distinct
4In this and the following paragraphs some biological vocabulary will be used which is explained in
Section 2.2.1
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types of modifications to these proteins have been described. The modifications often
are a variety of proteins binding to histone. It has been suggested that studying com-
binations of these modifications is of values as they encode biological functions [Strahl
& Allis, 2000]. An alternative suggestion is that the modifications are only additive and
combinations have no e↵ect Schreiber & Bernstein [2002].
Ernst & Kellis [2010] outline a method to distinguish between these two possi-
bilities. The input data they have available is the reads for binding of proteins along
chromatin which they convert to a binary of bound or unbound signal for each protein.
They employ a multivariate HMM with which they capture two types of frequencies:
the frequency of combinations of proteins found together on the genome and the fre-
quency of the spatial relationship of states across the genome. The resulting output is
a state assignment along the chromatin. Applying this model to human T cells5 they
identify 51 distinct states which they are able to link to distinct experimentally observed
characteristics as well as functional groups. The genomic locations also correspond well
to transcription start sites, transcription enhancing sites as well as active and repressed
genes. The most useful results from the analysis is a predictive model for states based on
histone modifications which is tested on independent measurements on di↵erent systems.
The kind of problem we wish to address in this thesis is to identify individual state
parameters when measurements are only made on population averages. Methods that
have a similar goal have been studied before with a variety of models and methods. These
methods take very di↵erent approaches to address this question varying from simple
deconvolution algorithm to more involved models based on HMM. We will examine a
few of the suggested models here.
Bar-Joseph et al. [2004] presents a deconvolution algorithm for cells that are
initially synchronised by stopping them in the cell cycle. In biological systems the syn-
chronisation is not perfect and eventually cells fall out of synchronisation over time.
It is developed to clean up the signal for yeast cells undergoing the cell cycle. The
method presented is a deconvolution based on a cubic spline interpolation as an initial
step to deal with missing data. The parameters for the spline are estimated using an
expectation-maximisation (EM) algorithm, which is an iterative method for finding the
maximum likelihood in models with latent variables. As an input the method requires
gene expression data for the cell cycle (a microarray time course is used in the applica-
tion) as well as the budding6 index. The budding index measures when the cell splits in
two which allows this to act as a measure for the cells temporal position in the cell cycle.
5a type of white blood cell
6a form of asexual reproduction found in yeast
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The problem studied here is somewhat simpler than a cellular transformation as yeast
cells are relatively synchronised across two cell cycles and the genes considered follow a
cyclic process.
Roy et al. [2006] propose an approach that is based on a multinomial HMM
(MHMM) which has distinct advantages to the previously used simple deconvolution
approaches [Bar-Joseph et al., 2004; La¨hdesma¨ki et al., 2005], it does not require specific
prior information about individual states such as the gene expression of each cell or the
distribution of cells in individual states. In this approach the hidden state represents
the distribution of cells across all possible populations. The observed states represent
measured gene expression in time. Parameter estimation is performed using an EM
algorithm and the posterior distribution is estimated using a sequential Monte Carlo
(SMC) approach7. The model is applied to cell cycle data as well as simulation data.
Since the latent state is in discrete time and assumes even distribution of time-points.
Existing models to study individual state parameters from population averaged
data present some promising results. The approaches taken are often limited as the
method is either tailored for a very specific application or it requires information in
addition to the gene expression time course that allows for further knowledge about the
states in the system. Roy et al. [2006] present a model that does not have these short
comings, it in fact aims to estimate a similar parameter as the one discussed in 3. It does
not provide information about the gene expression of individual states in the population
and it imposes restrictions on the temporal distribution of data though it can handle
missing data.
Chapter 3 starts with the description of a model called State Transitions using
Aggregated Markov Models (STAMM) based on previous work by Armond et al. [2014];
a latent stochastic process that obtains state-specific gene expression data as well as
number of intermediate states from homogenate population time courses. As discussed
above there exist models with similar aims such as deconvolving the cell cycle by Bar-
Joseph et al. [2004]; dissecting expression data with known mixtures [La¨hdesma¨ki et al.,
2005]; or a hidden Markov model to determine expression levels and fractions of cells
in each population [Roy et al., 2006]. Even though all such methods have strengths,
they also contain weaknesses addressed by STAMM. Firstly, it provides single-cell level
description of the transformations process and just like in the real system, this process
is hidden from observation due to averaging over multiple realisations (or cells). Second,
in our model the latent process is in continuous time and therefore there is no need for
7A SMC implements Bayesian recursion equations and is used when we wish to estimate posterior
densities of the state variables from known observation variables.
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special techniques to deal with missing data and unevenly distributed measurements.
Third, the model relies on very few assumptions such as fractions of mixtures; it estimates
all parameters from data. We also discuss in this Chapter a single-cell level simulation
process, which is used to test the model properties and assumptions. Then we also
outline a computationally e cient model selection procedure following and expanding
on previous work by Armond et al. [2014]. Results show that parameter estimation
works well even when violating assumptions. Only strong violations make estimations
di cult and in this setting, transition rates in particular are not estimated well.
Chapter 4 describes an application of STAMM to RNA-seq time course data of
an oncogenic transformation using a healthy breast cell line (MCF-10A) as the initial
population. We outline the pre-processing steps needed to apply the model to RNA-seq
data. Since observations are made as counts, it is often considered that a Poisson distri-
bution or a negative binomial distribution is the most fitting to such data. However, we
argue that once data has been pre-processed to allow for comparison between indepen-
dent samples the data are no longer integer counts, but rather can be usefully treated
as continuous. Then we show application of STAMM and show that it can be applied
to large data sets in a relatively short computational time.
Chapter 5 briefly discusses results from applying STAMM to a microarray time
course. This is obtained by reprogramming of secondary Mouse embryonic fibroblast
(MEF) cells to induced pluripotent stem cells. Then we show a possible next step once
parameters have been obtained by STAMM. This step includes comparison of estimated
parameters to new single-cell measurements, which in this case were carried out on
a di↵erent reprogramming system [Buganim et al., 2012]. We show that results are
comparable despite measurements being made on di↵erent systems and using di↵erent
methods.
Chapter 6 derives a model to investigate a slightly di↵erent system where less data
is available and serves as a proof of concept since data was not available in time for this
thesis. The gene expression is measured at the initial time point and the cell population
is subject to a stimulus of various strengths. At a later time, fractions of cells in two
distinct states are obtained by counting individual cells. An example of such a system is
a population of cells radiated during the cell cycle upon which some go into arrest leading
to apoptosis and some re-enter the cell cycle at a later time. This process is believed to
be dependant on heterogeneity at the initial time point. This model attempts to assign
a weight to each gene signifying its importance to the transformation process. Then we
outline a single-cell simulation procedure and apply the model to a single gene simulation
and a four gene simulation. Results show that a high noise level makes it di cult to
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estimate parameters but at low noise levels, parameters are estimated reasonably well
allowing us to at least distinguish between genes that are important for transformation
to ones that are not.
Novel contributions of this thesis are listed below:
⌅ Chapter 3
– Single-cell simulation study. We present a simulation framework imitating the
biological single-cell processes; single-cells undergo transitions between states
sampled from a statistical distribution and observed expressions are an aver-
age over cells. The strength of this approach is that single-cell state specific
parameters for data generation are known. Therefore, we can empirically test
estimation of parameters as well as the selection of correct number of states.
It also allows us to check estimation under violation of model assumptions
and additionally we can empirically investigate identifiability of the model.
– Full investigation of estimation, including tuning parameters. We discuss and
verify with simulations parameter estimation including setting tuning param-
eters using an unbiased approach. This is followed by sensitivity analysis
performed for tuning parameters.
– Computationally e cient model selection. For STAMM to be useful, an un-
biased estimation of model parameters, especially the number of states, is
important. We put forward a simple approach which uses a form of cross-
validation to determine number of states and other model parameters. We
show that this method is e↵ective during simulation and computationally
e cient.
– Implementation in R. We wrote a package for the STAMM model in R in-
cluding a simulated data set, published at https://github.com/anasrana/
stamm.
⌅ Chapter 4
– Application of STAMM to RNA-seq time-course data. We show, using an
example, how STAMM is able to analyse sequencing time-course data. The
example we chose is using RNA-seq data from an in vitro study of oncogenic
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transformation of a healthy breast cancer cell line (MCF-10A) under induction
of the oncogene src.
⌅ Chapter 5
– Comparing estimation to single-cell measurements for stem cell reprogram-
ming. In this Chapter the main contribution is firstly, computational i.e.
ensuring that estimation was reproducible as well as determining sensitivity
of Bayesian model selection to the choice of hyper-parameters. Secondly, a
comparison of estimated parameters from STAMM to single-cell level mea-
surements taken at di↵erent time points.
⌅ Chapter 6
– Proof of concept of a novel model. Here, we introduce a new model to under-
stand the importance of genes for radiation response. The gene expression is
only measured for the initial population subsequent measurements are frac-
tions of cells transforming at di↵erent radiation doses. We also outline a
single-cell simulation set-up and a brief application of the model to simulated
data.
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Chapter 2
Background
This thesis is multidisciplinary and as such requires an introduction to multiple distinct
areas. In this Chapter, we set out a description of background material, which should
prove useful to a reader with expertise in only one of the areas. The current Chapter is
therefore also split into three self-contained sections covering the individual areas. First,
Section 2.1 includes mathematical background for the main techniques used in the thesis
and introduces additional ideas that might place the work in broader context. Then,
Section 2.2 contains some background to the main biological ideas discussed. Finally, in
Section 2.3 the experimental techniques to obtain the data used in this work are outlined.
2.1 Mathematical background
This section contains the important basic principles we use to investigate biological
systems. We start o↵ by examining Markov chains and introduce basic principles for
discrete time and continuous time Markov chains. They are an essential part of the
model introduced in Chapter 3 and applied in later chapters. Then in Section 2.1.2 we
introduce the slightly more involved hidden Markov models, which are often applied to
biological systems and have similarities to the aggregate Markov chains introduced in
Chapter 3. Section 2.1.3 contains a brief presentation of the estimation procedure used
in our investigation. This is followed in Section 2.1.4 by a discussion on regularisation
during estimation in which two procedures penalizing for large parameter values and
overfitting commonly used to regularise estimated parameters are outlined. The con-
cept of identifiability, which can be of importance in estimation is defined in Section
2.1.5. Then we move on to a discussion on model selection in Section 2.1.6 and various
techniques for distinguishing between models. Finally, in Section 2.1.7 a very useful
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numerical tool is presented for integrating functions where a closed form solution is not
possible. This method is employed in the second model put forward in Chapter 6 of this
thesis.
2.1.1 Markov chains
In physics prior to the advent of statistical physics and quantum mechanics in the early
20th century, the world was modelled as deterministic. Of course, we now know that de-
spite many aspects of the observable world being deterministic there is an even larger set
of objects which does not lend itself to a deterministic description. Objects or ideas that
can be described using deterministic principles do at times derive from non-deterministic
e↵ects cancelling out or being only important at a di↵erent scale. Stochastic processes
are used to describe systems where deterministic principles fail. A concept shared by
many such systems is that they are evolving with a time dependent stochastic part. One
of the first attempts to describe such a system was the modelling of Brownian motion
by Einstein [1905], which paved the way for further research on this topic. Here we start
by defining some variables and simple principles governing one simple model that has
found widespread application, the Markov chain model.
Discrete time
Let X(t) be a time dependent continuous random variable and x(t1), x(t2) . . . are obser-
vations at discrete t1, t2, . . .. We write probability densities as p and the joint probability
density is written as p(X(t1) = x(t1), X(t2) = x(t2) . . .). In addition we can also write
the probability density of a set of observations at t1, t2, . . . conditional on observations
at ⌧1, ⌧2, . . . as:
p(X(t1) = x1, X(t2) = x2 . . . |X(⌧1) = x01, X(⌧2) = x02 . . .). (2.1)
where x01 6= x1 and is used to distinguish the two. The model we wish to consider is
a special case of a stochastic process: a Markov chain. The most important principle
underlying a Markov chain is the Markov assumption and it can be written in terms of
the conditional probability density. We introduce the notation of the current state at
tn of a system as xn with a continuous state space and discrete time; if we now write
the probability density of this measurement conditional on all preceding measurements
xn 1, xn 2, . . . x1 the following principle must hold:
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p(X(tn) = xn|X(tn 1) = xn 1, X(tn 2) = xn 2, . . . X(t1) = x1 . . .) =
p(X(tn) = xn|Xn 1 = xn 1), (2.2)
this is also known as the Markov property and it states, an observation is only condi-
tionally dependent on the observation immediately preceding it. Further, the Markov
property eqn. (2.2) and an initial distribution p(1) = p(X(t1) = x1) uniquely determines
a Markov chain in discrete time and with a discrete state space. This only holds because
any joint probability can be written as a product of subsequent transition probabilities
starting from the initial distribution. If we now write the transition probability as pij
as the transition from state i to state j (or as P in matrix notation) we can write the
distribution of a Markov chain at time t, p(t) where t 2 N as:
p(t) = p(1)P t. (2.3)
Continuous time
If we extend the Markov chain to continuous time but keep the state space discrete, we
have to introduce the generator matrix G. It uniquely defines a continuous time Markov
chain together with the initial distribution similar to a discrete time Markov chain. The
entries in the generator matrix are the transition rates from state i to state j satisfying
gi,j   0. Diagonal entries of the matrix are gi,i =  
P
j 6=i gi,j . We can now write the
time evolution as
d
dt
P (t) = GP (t) = P (t)G, (2.4)
which are known as the backward and forward equation respectively, where P (t) is a
matrix with the entries pij(t). If we are now interested in the state occupation as a
function of time p(t) and define p(t = 0) as the initial state distribution we can use eqn.
(2.4) and write
d
dt
p(t) = p(0)
d
dt
P (t) = p(0)P (t)G = p(t)G. (2.5)
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hidden state
observed state
emission probabilities
state transition probabilities
Figure 2.1: Schematic HMM. This diagram shows the general structure of an HMM.
The hidden state at time t is St = k, where k 2 {1, . . . ,K}. The white
arrows represent transitions between hidden states. Observed state at time
t is characterised by Xt = m for m 2 {1, . . . ,M}. Discrete emissions
probabilities from hidden states to observed states are shown as black
arrows.
It is often useful to rewrite eqn. (2.5) element wise form using the definition of the
generator matrix such that
d
dt
p(t) =
X
j 6=i
(pj(t)gj,i   pi(t)gi,j) , (2.6)
which is known as the Master equation and is useful in allowing us to derive many results
for Markov chains.
2.1.2 HMM
An extension to Markov chains that has found widespread application in biological sys-
tems is the Hidden Markov Model (HMM) initially developed by Baum & Petrie [1966].
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The big di↵erence to a classical Markov chain is that in an HMM the states of the Markov
chain are not directly observed. Instead, observations are made on outputs dependent
on the hidden states. The possible observable outputs can be discrete or continuous
while the hidden Markov chain has a discrete state space.
More specifically the hidden Markov chain has transition probabilities (as de-
scribed above) as well as emission probabilities, see Figure 2.1 for a schematic of an
HMM. We can write the hidden state process at time t as St in discrete time and with
a discrete state space i.e. St 2 {1, . . . ,K} with transition probabilities pi,j = Pr(St+1 =
j|St = i) and initial probability distribution p1 = Pr(S1 = k). Now we write the observa-
tion from this hidden Markov chain at time t as Xt; here we have to distinguish between
two types of outputs that can either be discrete or continuous. If the observation is dis-
crete i.e. Xt 2 {1, . . . ,M} we have emission probabilities bk(m) = Pr(Xt = m|St = k)
with j = 1, . . .M . If the observation is continuous i.e. Xt 2 RM we have to use a
continuous probability density function which is usually a weighted sum of Gaussian
distributions bj(Xt) =
PM
m=1 cjmN (µjm,⌃jm), where cjm is a weighting coe cient.
More information on HMMs can be found in MacDonald & Zucchini [1997] and
in Zucchini & MacDonald [2009] including sample applications.
2.1.3 Maximum likelihood
Once the model to be used to analyse data is established the question of parameter
estimation arises. The most widely used method in statistics for such a parameter
estimation from data is to write down and maximise the likelihood function
L(✓) = p(X = x|✓), (2.7)
where X and x are as defined above and ✓ is a set of parameters. This likelihood function
p(X = x|✓), is a joint probability density function over all observations x conditional on
the parameters ✓. Often it is more convenient to work with the log-likelihood function
with l(✓) = logL(✓). Since the logarithm is a monotone function the maximum of l(✓)
is the same as the maximum of L(✓). The advantage of the log-likelihood is that it can
be easier to work with as the log transformation can simplify the likelihood. In some
cases it is possible to obtain the maximum likelihood estimator (MLE) ✓ˆ that maximises
L(✓) and `(✓) in closed form. Especially in real world applications, this can be di cult
or there might not exist a closed form solution; in such cases we need to use a more
numerical approach.
To show one such approach we present a simple application of the principles and
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choose a common statistical model to illustrate the idea. Say there exists a model which
predicts the response variable y from a set of input variables x1 . . . xp. The illustrative
model we choose as an example system is the simple linear regression:
yi =  0 +  1 xi,1 + . . .+  p xi,p + ✏i, (2.8)
where ✏i ⇠ N (0, 2i ) is independent of observations,  j are unknown parameters, yi is
the response variable for the ith sample and xi,1, . . . xi,p are the predictor variables for
the ith sample. It is often beneficial to write eqn. (2.8) in vector form and include a 1
in the xi = [1, xi1, . . . , xip] vector and the  0 in the   vector to write yi = xTi  . The
maximum likelihood solution can be found by minimising the following equation, which
is equivalent to the least squares
RSS( ) = ky   x k22, (2.9)
where y is now a vector over all responses and has length n and x is now a matrix with
dimensions n⇥ (p+1). It is also known as the residual sum of squares (RSS) and is fact
sums RSS values for all input variables. This is a very simple way of finding parameters
of a model that best describes observations.
2.1.4 Regularisation
It can be of benefit to penalise complex models that contain too many parameters,
this will also prevent over-fitting and can help in interpretation of results. One way
of achieving this regularisation is to minimise the log-likelihood subject to a constraint
on model parameters. An analogous but easier to implement solution is to minimise
the log-likelihood with an additive penalty term on parameters. Choosing the example
mentioned in Section 2.1.3 we write
 ˆ = argmin
 
 ky   x k22+  g( ) , (2.10)
where k·k2 denotes the `2 norm, g( ) is the penalty function on   parameters and is
chosen depending on application and   is a parameter controlling the strength of the
penalty; a larger value corresponds to a stronger penalty. The strength parameter  
is generally set by cross-validation, or any other model selection criteria (see below for
a discussion of model selection). The penalty term itself can take several forms each
favourable in di↵erent applications, with the same primary aim of reducing model com-
plexity but with di↵erent properties. Here we present two possibilities, ridge regression
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and Lasso.
In ridge regression the added penalty term takes the form of a `2 norm over the
parameters g( ) = k k22. It penalises the magnitude of parameters and also shrinks them
towards zero but they are never exactly zero. Another method is least absolute shrinkage
and selection operator (Lasso), which has been used before but was reintroduced to the
statistics community by Tibshirani [1996]. It uses a `1 penalty i.e. g( ) = k k1. Just
like ridge regression Lasso penalises the magnitude of model parameters and therefore
the magnitude of larger positive or negative numbers are shrunk down. The advantage of
Lasso over ridge regression is that in addition to penalising higher values of parameters
increasing the strength of the penalty forces more and more parameters to be exactly
zero reducing model complexity, see Hastie et al. [2001] for more details.
2.1.5 Identifiability
For models where parameters are of physical importance, identifiability plays a crucial
role. It is important to remember that the concept of identifiability is a theoretical
concept. It does not relate to application of the model to real data but rather refers
to the model itself and an application to idealised potentially infinite amount of data
which is also noise free. Stating the definition formally, let M(✓) be a model with a set
of parameters ✓ from the parameter space ⇥. Then we say a model M(✓) is identifiable
when M(✓1) = M(✓2) holds if and only if ✓1 = ✓2 for all possible ✓1, ✓2 2 ⇥. In
other words if the model returns the same output for two di↵erent parameters it is not
identifiable.
More information on identifiability and some applications can be found in Sac-
comani et al. [2003], Saccomani et al. [2010] and Jacquez & Greif [1985]. It is a widely
studied subject especially in the context of linear models, but results for nonlinear models
are more di cult to obtain.
2.1.6 Model selection
The aim of a model is to enable description of a complex (sometimes not even fully
understood) phenomenon in a way that they are tractable by mathematics. Statistical
or even mechanistic models include in their core assumptions and simplifications of
the real world problem they are attempting to describe. In some cases, this can be
the only way to describe properties of the system. Often experiments are su cient
to distinguish between models and identify the one closest to the real world problem.
There are also cases where due to insu cient data or the type of data available two
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distinct models appear feasible. This problem is encountered especially when employing
statistical models and comparing observed data with predictions from such models. The
universal problem then becomes the comparison of model predictions to a set of noisy
data. Even in cases where the model itself is identifiable (see discussion above), the
existence of noise in observations poses a real di culty. In such cases the question that
one is really trying to answer is one of prediction. Model fit to data is not a su cient
measure. After all, the error between model prediction and a specific data set will not
carry over to a di↵erent data set; but it is still an important indicator and cannot be
discarded. One wishes to avoid over-fitting as this ensures that prediction not only works
for the fitted data but also can be applied more generally.
Cross-validation
One method that uses this idea in a data driven fashion is cross-validation. The basic
principle is quite simple, data is split into two independent subsets (the training set
and the validation set) and model parameters are estimated on the training set. Then,
predictions using these parameters are compared with the validation set resulting in a
performance score. A practical approach is called k-fold cross-validation. Here the data
set is split into k randomly chosen equally sized subsets, one subset is retained as the
validation set and the remaining k   1 subsets are used as training data. This step is
repeated for each of the k subsets and the performance score is combined giving one
score for each model. In some applications such as the ones discussed in later chapters
of this work, due to limitations in data it is only feasible to leave out one data point
at a time, also called leave-one-out cross-validation. This procedure is then repeated
for every model that is considered and the optimal model is chosen based on the best
score. It is clear that such an approach has drawbacks; when dealing with large data
sets computation times can quickly become infeasible since estimation is repeated for
k subsets, for all data and for all possible models. An additional problem can be that
due to the random splits in data the choice of the split influences results significantly.
Therefore, it is often advisable to try multiple splits and compare results.
AIC and BIC
To avoid lengthy computation time there are many methods to approximate model
selection results based on information obtained when estimating parameters, reducing
the number of computations to one per model and data. This is an obvious advantage
but it is a further approximation hence one has to be careful interpreting results and the
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choice of approximation used. In all such approaches the goodness of fit is juxtaposed
to model complexity i.e. since more complicated models will perform better during
estimation for a given data set we want to penalise models dependent on the complexity
of the model. Such methods due to historical naming convention are referred to as
information criteria. Here we will briefly introduce two such models. One of the most
widespread is the Akaike information criterion (AIC) formulated by Akaike [1974] and
the other is the Bayesian information criterion (BIC) presented by Schwarz [1978]. AIC
is computed using the log-likelihood l(✓) for model parameters ✓ and the degrees of
freedom d:
AIC =  2 l(✓) + 2d. (2.11)
It is derived using ideas in information theory namely the Kullback-Leibler divergence
between the true model for a data set and the used model. When dealing with small
sample sizes this measure is not satisfactory and is replaced by the corrected version the
AICc. It adds an additional term dependent on sample size n
AICc =  2 l(✓) + 2d+ (2 ⇤ d(d+ 1))/(n  d  1). (2.12)
The other information criterion, the BIC is derived using a Bayesian approach.
It is also applied for a log-likelihood approach just like AIC. The derivation of BIC
starts with the assumption that there exists a posterior distribution for modelsMi given
some data y written P (Mi|y). Here we introduce a subscript for models to easily label
di↵erent models as the di↵erence will not only be the parameters. Using Bayes’ theorem
we can write the odds of two models as:
P (Mi|y)
P (Mj |y) =
P (Mi)
P (Mj)
· P (y|Mi)
P (y|Mj) . (2.13)
The final term in eqn. (2.13), the ratio of marginal likelihoods, is also known as the Bayes
factor. The prior over models is typically assumed to be flat, then P (Mi) = P (Mj) for all
i, j the right-hand side of eqn. (2.13) just reduces to the Bayes factor. To approximate
the marginal likelihood P (y|M) we use the Laplace approximation which is a method
to approximate integrals. It yields the BIC score for a given model with parameters ✓:
BIC =  2 l(✓) + log(n) d. (2.14)
The penalty for complex models in BIC is larger than in AIC hence it will select for
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simpler models. Additionally as sample size n ! 1 and the model space includes the
true model BIC will select the correct model, i.e. it is asymptotically consistent unlike
AIC. However, AIC will sometimes perform better for smaller sample sizes [Hastie et al.,
2001]. Hence the decision of information criterion will be application dependent.
2.1.7 Monte Carlo integration
In many applications of mathematical models to real world problems one encounters
integrals without closed form solutions. For such cases numerical methods, which have
become particularly wide spread since advancements in computational power, allow for
large-scale computations in relatively short time. Monte Carlo integration is one such
example. Generally, Monte Carlo techniques are ubiquitous for classes of problems which
include random numbers.
If we have a function f(X) of a random variable X which is uniformly distributed
between a and b, we can write the expectation of f(X) as the integral
E(f(X)) =
1
b  a
Z b
a
f(x)dx, (2.15)
The law of large numbers states that the sum of n random variables divided by
n converges to the expected value of the random variable as n ! 1. This is a very
powerful idea and since we know that the function of a random variable is also a random
variable we can extend this to the function of a random variable f(X). As the number
of samples n taken from random variable X approaches infinity
1
n
nX
i=1
f(Xi)! 1
b  a
Z b
a
f(x)dx as n!1. (2.16)
The left hand side of eqn. (2.16) is therefore an asymptotically consistent estimator of
the expectation of f(X) i.e. it converges to the right hand side as n!1. Eqn. (2.16) is
the Monte Carlo estimate of an integral and an important issue to always bear in mind
for this method is convergence, as without the result having converged su ciently, they
are meaningless. Therefore, in applications the shape of the probability distribution of
X plays a central role in determining how well the Monte Carlo integral will converge.
This means if function f(X) has a large weight for a value of X which is unlikely to be
sampled then for finite n the estimate will be bad. In general for finite n the solution will
only be approximate as proper convergence is not possible for finite n. More information
on Monte Carlo integration can be found in the review article by James [1980] and in
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Norris [1998, Chapter 5].
2.2 Biological background
In biological systems, distinct states and especially states that are indicative of disease
can often be characterised by changes in gene expression levels [DeRisi et al., 1997;
Spellman et al., 1998; Eisen & Brown, 1999; Brown & Botstein, 1999]. It is important
to first understand the role played by genes in cells and also what it is we mean by
expression of a gene, therefore below we present a brief introduction to these topics as
well as specific examples where changes in gene expression have been found to play a
central role in changes of cell states.
2.2.1 The cell
If we define reproduction as a basic principle of life, the cell is the smallest unit that
autonomously allows for this process. Independent of the process of reproduction, to
ensure a faithful reproduction of organisms, information is passed on from one generation
to the next. This information takes the form of a molecule, Deoxyribonucleic acid (DNA),
organised in a double helix structure made up of two DNA strands. Information on such
a strand is stored as a sequence of four distinguishable subunits. These four subunits
are adenine (A), guanine (G), cytosine (C) and thymine (T), where C-G and A-T base
pairs held together by hydrogen bonds make up the DNA double helix. Some sequences
of the DNA code for proteins (coding region) and are known as genes. There is still
debate about the extent to which DNA is made up of coding regions and noncoding
regions; the di↵erence between organisms can be very large. In humans only about 2%
of DNA is considered to specifically contain genes [Elgar & Vavouri, 2008]. The initial
idea that a major part of noncoding DNA is junk has been refuted recently as part of
the international project of the ENCODE consortium [Pennisi, 2012]. Some of these
areas have been shown to contain areas for proteins to bind and influence gene activity,
or stretches where chemical modifications can switch o↵ part of the DNA. It has also
been established that regulation of genes is much more involved than previously thought
and areas of DNA far away from a given position can influence gene expression at that
position. The first step of converting coding regions of the DNA to proteins is known
as transcription. In this process, information from the DNA is read o↵ and converted
into a single stranded molecule of ribonucleic acid (RNA); more specifically, the type of
RNA used is known as messenger RNA (mRNA). The following step involves some post-
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DNA transcription mRNA post-transcriptionalmodification
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mRNA
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translation
influences
Figure 2.2: Gene expression. The central dogma of molecular biology states that genes
on DNA are transcribed to mRNA, which is transformed to mature mRNA
by post-transcriptional modifications such as splicing. The mature mRNA
is then translated to proteins. This final product, which plays a central
role in the functions of cells in turn also influences the transcription step
as well as the post-transcriptional modification step.
transcriptional modifications, where the mRNA is modified to mature mRNA. There
are many such modifications the cell performs, but an important one is splicing. This
process removes regions of mRNA called introns1 that do not code for proteins after
which the remaining exons2 are spliced together. There are multiple ways to splice a set
of exons, which can lead to many di↵erent proteins being read from the same sequence on
DNA. Finally, proteins are synthesised from mature mRNA during the process known as
translation. During translation, mRNA information is read in groups of three subunits
called codons, hence there are 43 = 64 codons which are mapped to 20 amino acids
used to make proteins. These final DNA products then perform numerous functions in
the cell including steps in their own synthesis. These three steps together are known
as gene expression and form the central dogma of molecular biology, for a Summary
see Figure 2.2. The DNA molecules contained in cells are more than two metres long
and to economically pack them inside cells, which also contain vast amounts of other
material, they are normally in packed structures known as chromatin. This is quite
simply a combination of proteins with a special a nity to bind DNA allowing DNA to
be wrapped and packed very tightly in the nucleus of the cell. In addition to packing
DNA, it also serves a functional purpose in that the topology of the packing hides and
exposes certain genes on DNA. In a system where gene expression occurs via several
protein dependant steps hidden genes cannot be expressed since regulatory proteins
cannot interact with them.
1a region inside a gene sequence that binds together the gene and is subsequently removed
2a region on the DNA that codes for proteins
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Each step during gene expression outlined above happens at a di↵erent time
scale therefore when interpreting biological data it is important to keep in mind that the
e↵ect one sees on gene expression at a given time might be due to a protein interaction
process, which took place at an earlier time point. The time scale can vary from seconds
for proteins [Herce et al., 2013] up to 16 hours for the largest gene [Tennyson et al., 1995].
This of course becomes even more complicated once interactions between the di↵erent
components involved are accounted for.
The control of gene expression is responsible for characteristics of a cell. As in-
deed a lung cell and a brain cell have identical genetic information, but gene expression
is responsible for defining a cells purpose. This is in part controlled by material outside
of the coding region. Daughter cells in addition to inheriting genetic information from
parent cells, also inherit information that determines the characteristics of the cell unre-
lated to DNA, i.e. daughter cells of a cell in lungs will remain lung cells. The umbrella
term often used to describe all types of material that could pass on this information
not directly part of DNA is epigenetic material. The final word on epigenetics has yet
to be spoken but two types of information passed on in this manner are: Firstly, the
chromatin structure which determines active and inactive genes and to some extent the
way they are read o↵. Active sections of chromatin are called euchromatin and inactive
parts are called heterochromatin. Secondly, DNA methylation that is the addition of a
methyl group to certain bases in DNA, altering expression of genes.
Biological changes in state, which are the focus of this work, can be described
in many di↵erent ways. Some changes in state are due to changes in gene expression.
Other changes in state can also be epigenetic without direct changes in gene expression.
Although both of these types of state changes are deeply interlinked, they can occur
at vastly di↵erent time scales. Here we will focus on state changes directly, due to
changes in gene expression. Such changes in state have been investigated experimentally
in various settings such as cancer [Lee et al., 2010; Gupta et al., 2011] and stem cells
[Ohgushi & Sasai, 2011; Plath & Lowry, 2011] among others.
Further information on the cells in general as well as epigenetics can be found in
Alberts et al. [2007, Chapters 1,7]. A specific overview of epigenetics has been attempted
in Goldberg et al. [2007] and its e↵ect on gene expression in Gibney & Nolan [2010].
2.2.2 Cancer biology
An area of biology that is of great importance due to its impact on large populations and
where state changes play a critical role is the study of cancer. Cancer is an extremely
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complex disease and attempts have been made to determine basic underlying principles,
which is referred to as the ’Hallmarks of cancer’ [Hanahan & Weinberg, 2000, 2011].
Genetic aberrations play a central role in this disease as many carcinogens (agents that
can cause cancers) directly influence DNA sequences or are themselves mutations of
genes naturally occurring in the cell. These defects range from point mutations on
single base pairs all the way to deletions of large sections of DNA. Especially the process
of cell division is highly susceptible to such attacks; in healthy cells there is a DNA
repair mechanism in place that prevents changes from becoming permanent or leads to
apoptosis (programmed cell death) if repair is impossible.
One important principle shared among cancer types is the unbound proliferation
of cells leading to the build up of concentrated cell masses, also known as tumours. Note
that many such tumours are benign since they do not transform into cancers. The bod-
ies defence mechanisms against such unchecked proliferation are circumvented either by
introduction of oncogenes or mutations in tumour suppressor genes. Oncogenes are mu-
tations in genes that result in a protein, which drives uncontrolled cellular proliferation,
resulting in a tumour. These proteins do not respond to the natural signals that inhibit
cell division, hence the proliferation is uncontrolled and cannot be kept in check by the
cells defence mechanisms against such growth. Alternatively, mutations can occur in
genes responsible for onset of apoptosis or DNA repair (also known as anti-oncogenes).
Genetic mutations are especially problematic if they occur in the germline3, as exempli-
fied by LiFraumeni syndrome [Li & Fraumeni, 1969], where the mutation in an essential
tumour suppressor gene is passed on to o↵spring and leads to a hereditary predisposition
to a large number of cancer types.
It is important to note that one mutation or defect is not su cient to lead to
the development of cancers; in fact several processes need to be a↵ected. Additional
processes developed by cells to defend against invading cancers include a limit on the
number of times a cell can divide. Cells also rely on external growth signals to start
division as well as external growth inhibition signals to stop division. Cancers are known
for uninhibited expansion, for which they need nutrients and therefore develop the ability
to initiate the deployment of additional blood vessels; a process known as angiogenesis.
Tumorous cells can become metastatic this is especially dangerous. It is the stage when
they develop the ability to break o↵ from the main tumour and invade surrounding
organs, tissues or even distant parts of the body.
As mentioned above an oncogene is a gene that can cause cancer and the first
such oncogene (v-Src) was discovered in the late 1970s and early 1980s (Martin [2001]
3cells from which egg or sperm cells are derived
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and references therein) after the initial discovery almost 70 years earlier; hinting at the
possibility to induce solid tumours in chicken using a filtered agent by Rous [1911]. Inves-
tigating the Rous sarcoma virus in chicken the v-Src was discovered. Further research
determined that a variant of v-Src, called c-Src is also contained in normal chicken.
This discovery fundamentally changed the understanding of cancer which until then had
been ascribed to viral causes. Later this gene was also found in humans and since this
discovery, it is probably the most widely studied oncogene; despite this there remain
many unknowns. The protein from this oncogene has many downstream interactions
with numerous other proteins. Hence, it is not surprising that in almost 50% of tumours
originating in breast, colon, liver, lung and the pancreas the c-Src interaction pathway is
activated Dehm & Bonham [2013]. Due to mutations, c-Src is overexpressed4 and acti-
vated leading to the constant activation of downstream signalling pathways that ensure
survival, proliferation and invasion, and therefore to development of cancers.
Further details on cancer biology and the role of genes can be found in Weinberg
[2013].
2.2.3 Stem cells
Central to cellular development is the creation of distinct di↵erentiated cell types from
a small collection of undi↵erentiated cells in the embryo referred to as embryonic stem
cells. Clearly, this transformation involves state changes on the genetic and epigenetic
level. In recent years there has been an increase in research in these areas, especially
due to its potential in applications to personalised medicine; the next big frontier in
medicine. The idea is to enable induction of alternative cell fates from embryonic cells
or to enable development of cells that allow for a change in cell fates of tissues or blood
samples. Examples include the development of neurons from cells that are responsible for
creating extra cellular matrix known as fibroblasts [Vierbuchen et al., 2010; Pang et al.,
2011] or the development of muscle cells from fibroblasts [Ieda et al., 2010; Efe et al.,
2011]. All types of undi↵erentiated cells that can produce di↵erentiated cell types are
comprehensively known as stem cells (SC). Another property shared by all stem cells is
that they can di↵erentiate to produce more stem cells multiple times. Broadly speaking
there are two types of stem cells. Embryonic stem cells (ES cells) are cells derived from
an embryo in its early development and adult (or somatic) stem cells, which are found in
fully developed organs. The main di↵erence between the two types is how many types of
cells they can di↵erentiate into. ES cells are pluripotent i.e. they can di↵erentiate into
4expression is higher than normal
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many possible cell types. Adult SCs, also known as multi-potent stem cells, can only
di↵erentiate into limited cell types often serving the function of replenishing damaged
cells of a single organ. For medical applications of course ES cells are more useful, but for
some people there are ethical concerns associated with their usage and their harvesting;
independently of the rationale behind these concerns, it does create issues in research if
such cells are used.
A new approach, proposed by Takahashi & Yamanaka [2006], is to use di↵eren-
tiated somatic cells and derive induced pluripotent stem cells (iPS cells), which have
distinct advantages if successful. These iPS cells are able to di↵erentiate to various cell
types and could in future allow for personalised medicine. The process in creating iPS
cells involves artificially inducing 4 genes (reprogramming factors) for several days and
indeed cells have been found experimentally, which have properties comparable to ES
cells. More detailed studies show that iPS cells are influenced by the used reprogram-
ming factors and there are epigenetic di↵erences between ES cells and iPS cells [Carey
et al., 2011; Bock et al., 2011]. One important concern is the di↵erence in DNA methy-
lation of iPS cells and ES cells in terms of epigenetic material that would make their use
di cult, this problem is now being addressed [Bagci & Fisher, 2013] along with other
safety concerns.
Further information on stem cells, ES cells, somatic cells as well as iPS cells, can
be found in Lanza et al. [2009] and in Lanza & Atala [2013].
2.2.4 Cell cycle
An essential step governing the division, di↵erentiation and maturation of all cells is the
cell cycle. In simple terms it is the process by which two daughter cells are produced
from one mother cell by duplication of the cell contents; most importantly the DNA.
Details of the process can vary between organisms as well as between di↵erent stages of
development. Most cells in the human body are not taking part in the cell cycle, but
are in a resting phase. The most basic principles of the mammalian cell cycle can be
summarised into four phases:
⌅ G1 phase The first gap phase during which cells increase in size. The G1 phase
includes a restriction point up to which the cell is driven by external stimuli. Once
the cell has passed the restriction point it can progress through G1 independently.
⌅ S phase The transition from the G1 to the S (Synthesis) phase contains a powerful
checkpoint after which the cell is committed to duplication. During the S phase
itself DNA is replicated.
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⌅ G2 phase The second gap phase is not present in all organisms. In short, the cell
keeps increasing in size, synthesises proteins and prepares for mitosis. It contains
a checkpoint to determine DNA damage and stops the process.
⌅ M phase The final step in the cell cycle is the mitotic (M) phase. The duplicated
chromosomes are separated into two cells and a new nucleus is created. The M
phase also contains a checkpoint to ensure the cell is ready for division.
Despite all these checks and balances in place during the cell cycle, uncontrolled
cell division still occurs in tumourigenesis as mentioned above. Intervention on the cell
cycle plays a central role in unbound growth of cells. In many cases proteins essential
during check points are mutated, inhibited or overexpressed [Williams & Stoeber, 2012].
Understanding and perturbing elements in the cell cycle could be a good approach for
potential cancer treatments since the mammalian cell cycle is conserved across a variety
of cell types; at the same time it plays a central role in cancers.
The cell cycle is also sensitive to UV radiation, which is a well known carcinogen.
UV radiation incident on a cell can lead to DNA damage, and if the damage is too
extensive, cells can undergo apoptosis. If the damage is not too widespread, some cells
will arrest and re-enter the cell cycle at a later time. Radiation has an e↵ect on gene
expression, which is also related to the intensity of the radiation as di↵erent genes become
active to respond to the stimulus, but more importantly the type of response is driven
by expression of certain genes. [Gentile et al., 2003].
More information about the cell cycle can be found in Alberts et al. [2007, Chap-
ter 17] and its relationship to cancer in Weinberg [2013, Chapter 8].
2.3 Experimental background
In this section we explore two techniques to obtaining time-course assays for genome
wide gene expression data. Current techniques for such measurements are very limiting
as the the required experiments can only be carried out on a population level. There
exist techniques for single cell measurements [Buganim et al., 2012], but these techniques
are not yet fully developed and only allow measurement of a limited number of genes.
Initially to be able to obtain these measurements it is necessary to create a homogenate
from the sample, which is done by mechanically breaking down cells using a variety
of di↵erent procedures. After which di↵erent subsets are filtered out of the mixture to
perform microarray or sequencing experiments. For instance to perform RNA sequencing
(RNA-seq) experiment mRNA are filtered out of the homogenate.
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2.3.1 Microarray
Di↵erent stages of gene expression can be measured using microarrays. Here we present
the one most commonly used for expression profiling, the DNA microarray, with the aim
to measure mRNA levels after reverse transcription to cDNA5. Many types of microar-
rays exist to measure cDNA but broadly they can be sorted into two groups: the high
density chip based microarrays, such as the high density oligonucleotide chips [Lockhart
et al., 1996]; and the alternative bead array chips, such as described in [Kuhn et al.,
2004]. Below we will outline the former method corresponding to the type of data used
in Chapter 5, only the initial description is di↵erent, normalisation steps will be the
same. The basic principle of cDNA microarrays is based on high-density array with
DNA sequences printed on them. The sample mRNA reverse-transcribed to cDNA la-
belled in two di↵erent colours (red and green). Equal proportions of the labelled colours
are mixed together and hybridised to the array and using a scanner, fluorescence mea-
surements are made for each colour. The resulting expression is obtained by the ratio of
the measurements in each colour, see Phimister [1999] for further information. To ensure
measurements are comparable between di↵erent samples and even di↵erent experiments
it is important to normalise each sample. The quantity measured initially is the inten-
sity of fluorescent light emitted, but the exact value of the intensity measurements is not
reproducible. The most robust normalisation method is based on subtracting a position
and intensity (A) dependant constant from the log ratios of the intensity measurements
of emission in the colour green, labelled G, and emission in the colour red, labelled
R. The fluorescence emission in di↵erent colours are achieved by staining two cDNA
populations with di↵erent substances:
log2
R
G
  l(A, j), (2.17)
where l(A, j) is the lowess fit [Cleveland, 1979] to the plot of log2R against log2G
rotated counterclockwise by 45 . More detail on normalisation and cDNA microarray
measurements can also be found in Dudoit et al. [2002].
2.3.2 RNA sequencing
Until recently the most prevalent method for obtaining gene expression data, which is
essential to understanding disease states, has been DNA microarray measurement. One
drawback is that observations are relative and indirect i.e. measurements via fluores-
5Complementary DNA, DNA reverse-transcribed from mRNA
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cence intensity and ratio of two colours. The approach outlined above, of tagging with
two distinct fluorescent colours, is useful for normalising measurements. Additionally,
microarray measurements are limited by prior knowledge of genes, since arrays can only
be constructed to include sequences of known genes. A new contender that attempts to
address some of the shortcomings of previous methods is RNA-seq, developed roughly
5 years ago [Mortazavi et al., 2008; Nagalakshmi et al., 2008]. RNA-seq measurements
are integer count data and measurements cover the whole genome independent of prior
knowledge. The unit of measurement is either counts per gene (cpg) or counts per base
pair (cpb) if we normalise for gene length.
Experimental protocol
RNA-seq experiments also attempt to measure mRNA obtained from homogenate, just
like microarrays. The first step is a random fragmentation of the sample mRNA. The
next step is a reverse-transcription of the fragmented samples to cDNA. Next comes
a polymerase chain reaction (PCR) step which is a method of amplification to obtain
more copies of DNA from a few copies of a slice of DNA and is performed multiple times.
This step is the source of one type of systematic error since di↵erent sections of DNA
have di↵erent susceptibilities to PCR amplification. In the next step each fragment is
sequenced in a high throughput machine; resulting sequences are referred to as reads.
These reads can now be mapped to a known genome or transcriptome6 resulting for one
count for each fragment of gene found. Alternatively, reads can also be used to construct
a transcriptome without mapping it to a known genome (de novo assembly). Figure 2.3
from Li et al. [2012] summarises this protocol.
Normalisation
Though RNA-seq avoids some of the issues associated with microarray measurements,
it still has its own di culties that need to be overcome before analysing any type of
data. The first, as already mentioned above, is the systematic error due to the PCR
step. Another is due to the random fragmentation step; since larger genes will have more
fragments resulting in a higher per gene count. Due to these reasons the total number
of counts is also not conserved across di↵erent samples.
Therefore there is a real need for a normalisation step prior to comparison of data,
to ensure the e↵ect of these problems are minimised. The issue of di↵erent gene lengths
can be removed by simply normalising for gene length, which is a known quantity when
6collection of all RNA
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Figure 2.3: RNA-sequencing (RNA-seq). The most commonly used modern genome
wide assay. From a homogenate cell sample, mRNA is filtered out and
passed through this pipeline to give integer count expression values for
genes. Figure from Li et al., Normalization, testing, and false discovery
rate estimation for RNA-sequencing data, Biostatistics, 2012, 13(3), by
permission of Oxford University Press.
mapping counts to a genome. Additionally, this is only an issue when comparing genes
in the same sample. For comparisons between samples, this step is unnecessary since
gene length is constant across samples. However, normalisation is also an important step
comparing di↵erent samples, it arises most notably in di↵erential expression and is also
addressed in this context. In RNA-seq data, unlike for microarray data, the question of
normalisation has yet to be settled. The method most commonly used, is to normalise
all samples to a fixed number of reads, but this leads to issues as can be illustrated using
a simple example.
SayNi,j is the total number of reads in experiment i for gene j with the units [cpg].
In a simple case N1,j ' 2N2,j for all genes and hence sequencing depth of experiment 1
is twice the sequencing depth of experiment 2. In a slightly more complex example, the
issue becomes clear. If we now consider j = 1, . . . , 100 to have N1,j = 1 and N2,j = 2
and for j = 101 N1,j = 100 and N2,j = 0 both experiments have the same sequencing
depth which would suggest all genes are di↵erentially expressed. However, it would be
more realistic to consider that the sequencing depth of experiment 2 is twice that of
experiment 1 and that only gene j = 101 is di↵erentially expressed. Therefore, a good
strategy would be to identify genes that are not di↵erentially expressed and calculate
a sequencing depth just for those and use it for the whole sample. One idea would be
29
!ht
Figure 2.4: Example. The top panel shows a scatter plot of arcsinh transformed gene
expression measured at 0 hr and 48 hr. For details on the experimental
measurements and the reason for the transformation see Chapter 4. The
bottom panel shows the same data transformed as described in eqn. (2.18)
to perform a normalisation. The horizontal red lines represent a possible
cut-o↵ forM -values and the vertical green line represents a possible cut-o↵
for A-values.
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to identify housekeeping genes7 for the particular application at hand and calculate a
sequencing depth, but this is an unsatisfactory solution since it does not generalise (each
application would have di↵erent housekeeping genes) and requires further experiments or
prior knowledge. Bullard et al. [2010] propose a method using quantiles instead of total
counts. Robinson & Oshlack [2010] propose a method based on total count normalisation
called trimmed mean of M values (TMM). The idea is to impose a cut-o↵ on log-fold
change M -value and the absolute expression level A-value and calculate the sequencing
depth using what remains. The M -value and A-value is calculated using the definition
Ni =
P
j Ni,j (where Ni has the units [cpg]) as follows:
M i
0
i,j = log2
Ni,j/Ni
Ni0,j/Ni0
Ai
0
i,j =
1
2
log2
 
Ni,j/Ni ·Ni0,j/Ni0
 
.
(2.18)
The bottom panel of Figure 2.4 shows the transformation eqn. (2.18) applied to
two RNA-seq measurements8. The red lines shows a possible cut-o↵ on theM -value and
the vertical green line shows a possible cut-o↵ imposed on the A-value, where both M
and A are dimensionless. Table B.1 shows raw count data as well as normalised data for
20 genes and 7 time points.
In the R package edgeR the method normalisation method outlined above as well
as a few others have been implemented for application to RNA-seq data [Robinson et al.,
2010]. A summary comparing di↵erent normalisation methods can be found in Oshlack
et al. [2010].
7genes that are supposed to remain constant
8see Chapter 4 for details on the measurements
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Chapter 3
State transitions using aggregated
Markov models
3.1 Introduction
Diverse biological processes have been observed to undergo transitions under influence of
a stimulus. These transitions lead to changes on a cellular level between distinct pheno-
typic states. The source of these phenotypic changes can be morphological, epigenetic,
or even at a protein interaction level.
One big obstacle in understanding the source of such phenotypic changes at a
single-cell level is that observations are generally not at the single-cell level since it is only
possible to perform observations on a population level. This restriction is experimental
in nature and although sometimes it is possible to make observations on a single-cell
level there are often limitations on the amount of information that can be obtained as
discussed in detail in Chapter 1.
The model we explore is called State Transitions using Aggregated Markov Mod-
els (STAMM) initially proposed by Armond et al. [2014]. This is a stochastic model
identifying state level information for single-cell transformations using population level
data. Single-cell level dynamics, latent in the model, are described by a Markov chain,
which is then aggregated over multiple cells. This model has been applied to cancer
cell lines [Casale et al., 2013] and stem cell reprogramming (see Chapter 5) there still
remains work to be done in obtaining a better understanding of this model. We use
single-cell level simulations to probe model properties and model assumptions.
A type of model that has found widespread application in the description of
such systems and shares certain characteristics with STAMM, is the Hidden Markov
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model (HMM). Many examples of real world applications of HMMs exist including the
deconvolution of population level microarray data [Roy et al., 2006]. Other types of
models that attempt to study population level heterogeneity exist. Some of these models
use deconvolution algorithms for the description of the cell cycle and for microarray
data where additional information is required for the models [Bar-Joseph et al., 2004,
2008]. The main advantage of STAMM is that the latent model is in continuous time
and therefore application to time-course data with uneven time-points is built into the
model. This is discussed in more detail in Chapter 1. Another type of model that is even
closer to STAMM was studied by Kalbfleisch et al. [1983] but this model investigates
panel data, often near or at equilibrium.
In this Chapter we follow and expand on previous work done starting with a
detailed description of STAMM in Section 3.2 including a detailed description of model
assumptions. In Section 3.3 we outline parameter estimation including a way to perform
model selection as well as an e cient and unbiased estimation pipeline. Then we specify
the single-cell simulation setup (Section 3.4) before moving on to the results from single-
cell simulation data in Section 3.5. These are split up into results from performing a
small-scale simulation to probe the model and test sensitivity to breaking assumptions;
and large scale simulation results to demonstrate the whole pipeline.
3.2 Model outline
3.2.1 The STAMM model
STAMM defines a latent stochastic process on the single-cell level that isn’t directly
observed. Using the latent stochastic processes and aggregating across cells, we can
obtain a cell-population level likelihood. The latent single-cell process is described using
a Markov chain with a discrete and finite state space but it is continuous in time.
Biological states in the system are identified with the state space of the underlying
biological system, indexed by k 2 {1, ...,K}. Transitions between states k and k0 are
determined by transition rates between these states denoted by w = {wk,k0}. It is
important to note that state changes are only defined for the whole entity of a cell and
not over single genes or proteins. Assuming that cell death and cell doubling compensate
each other, i.e. the number of cells is conserved at all time t, the probability for any cell
to be in state k at any given time t can be obtained by solving the master equation of
the Markov chain. The resulting state occupation probability for the population given
the transition rates pk(t|w) is a function of time and also the state transitions.
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Figure 3.1: Model description. (a) In any biological system undergoing transitions
between multiple states where the time of transition is stochastic, cells
states are heterogeneous in the population at any given time. (b) Assays
performed on homogenates of that cell population will only yield data
averaged over sampled sub-populations. (c) We describe this system with
State Transitions using Aggregated Markov Models (STAMM) where single-
cell level processes are described by a latent continuous-time Markov chain
which is aggregated over cells to give a likelihood (see Section 3.2.1). The
Markov chain has a discrete state space which corresponds to biological
states of the system (shown in di↵erent colours). Estimation of parameters
in STAMM is performed using population level data. (Figure adapted from
Armond et al. [2014].)
This model can be applied to any type of time-course data, including transcript
or protein abundance. Here unless otherwise stated we will focus the description, with-
out loss of generality, on gene expression data. Let xj(t) be the cell-population-averaged
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gene expression of gene j at time t, obtained from a homogenate assay such as RNA-seq
or microarray expression. The units of xj(t) and t will depend on the application, for
RNA-seq the units of gene expression are [cpg] for microarrays the units are intensity. In
simulation the time t is in arbitrary units. When investigating transitions it is prudent
to design experiments with an initial state that is reasonably homogeneous, therefore
our model assumes that initially all cells in the population occupy the same state. This
is often part of the experimental design when investigating changes from an initial ho-
mogeneous starting population. At any subsequent time point, cells exist in a mixture of
states, hence measurement xj(t) made on a population level is an average over multiple
states. We further assume that there is a mean expression level per gene constant across
a state. This is denoted by  kj , the gene expression level for gene j 2 {1, . . . , p} in state
k which has the same units as the gene expression.
In the limit of large numbers of cells the fraction of cells in any state k is given by
the state occupation probability pk(t|w). We can now write the observed average gene
expression, xj(t) for gene j at time t, as the sum of all occupation probabilities weighted
by their respective gene expression signatures. The resulting model for the average gene
expression from a latent Markov chain model is written as:
xj(t) =
X
k
pk(t|w) kj = p(t|w) j , (3.1)
where the right hand side is the vectorised form of the model, with the row vector
p(t|w) = [p1(t,w), . . . , pK(t,w)] and column vector  j = [ 1j , . . . , Kj ]T . Assuming
an additive Gaussian noise model with gene-specific noise variance  2j we arrive at the
likelihood:
L  w, j , j | {xj(t)}  = TY
t=1
N  g(xj(t))|g  p(t|w) j  ,  2j   , (3.2)
whereN (·|µ, 2) denotes a Normal density with mean µ and variance  2 and the function
g denotes a transformation whose choice depends on the data type under investigation.
The transition rates in the likelihood enter via the state occupation probability (see eqn.
(3.5) for an example) and the product on the right-hand side of eqn. (3.2) is taken
over the discrete time points t = {1, . . . , T} at which experimental measurements are
available, this only serves to label time points and does not assign a value. The transition
rates in the expression of p(t|w) connects estimation for di↵erent genes, later we discuss
a procedure which fixes transition rates, thereby allowing independent estimation for
genes. The number of genes p will typically be larger than the number of states K but
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it is not a requirement for the model.
Applied to microarray experiments which use ratios of fluorescence intensities be-
tween measurements in the red spectrum R and green spectrum G, the transformation g
used is log2 [Dudoit et al., 2002], for further details see Section 2.3.1. When investigat-
ing RNA-seq data we use arcsinh as the transformation [Ho↵man et al., 2012; Johnson,
1949], defined as arcsinh(x) = ln(x+
p
(x2 + 1)) (for more details see Section 4.3). RNA-
seq data cannot be normalised in the same way as microarray data, most importantly
because it contains measurements which are exactly zero. The arcsinh normalisation is
useful here, because unlike the log transformation it does not have a singularity at zero
while having the same variance-normalisation properties.
To use the likelihood it is necessary to compute the state occupation probabilities
at any time t observations are made, which we cover below.
Markov chain and the master equation
Until now we have not placed any restrictions on the latent Markov process in this
model and we have formulated the likelihood eqn. (3.2) for a general case. To classify
the Markov chain we first clarify some notation: recall the states of the latent process
are labelled as k 2 {1, . . . ,K} and denote transition rates between states k and k0 as
w = {wk,k0}, when the rate of the transition is equal to zero for a givent k the transition
does not exist for that model. Using these parameters we can record the structure of
any Markov chain, the topology of which has implication on identifiability of the model
(for further discussion see Section 3.2.2). In this discussion we limit ourselves to a pure
birth process where wk,k+1 6= 0 for all k and zero otherwise including wk,k+1 for k = 0
and k = K. This means that the Markov chain excludes branches, starts at k = 1 with
a final absorbing state. The resulting master equation is written as:
dpk(t)
dt
= wk 1,k pk 1(t)  wk,k+1 pk(t). (3.3)
We can write the master equation in matrix notation using the generator matrix
G(w). It is a K ⇥ K matrix where the only non-zero entries are on the diagonal,
gkk =  wk,k+1, and the subdiagonal gk k 1 = wk 1,k. This allows us to write the master
equation using vectors and matrices:
dp(t|w)
dt
= G(w)p(t) (3.4)
In investigating transition processes (such as Chapters 4, 5) generally an experimental
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design is chosen such that the initial cell population is in the same state. Therefore we
can set the initial conditions for the state occupation probability, p(0) = (1, 0, 0, . . .).
This means all cells are in state k = 1 at t = 0 just before the cell population is perturbed.
This allows us to write the closed form solution for the state occupation probability as:
p(t|w) = exp (G(w) t)p(0). (3.5)
This expression is also used to evaluate the likelihood (eqn. (3.2)) of the model for
di↵erent parameters.
Model Assumptions
Wemake a number of assumptions in the above model derivation. Here, we focus on some
of the key assumptions made regarding the transition process on a single-cell level and
investigate them further. Ensuring an analytically tractable latent state change model
makes these assumptions necessary. In the discussion below we discuss how appropriate
these assumptions are, if and how they can be relaxed, and if and under what conditions
they can be justified.
First, we assume expression of a gene remains constant while it remains inside
a given state. The single-cell expression of each gene is modelled by a piecewise flat
trajectory where expression changes are instantaneous due to a change in state. It
also has the e↵ect that the only time-dependence in the likelihood is due to the state
occupation probabilities of the Markov chain. In this simple approximation interactions
between genes are largely ignored and not modelled explicitly; allowing us to formulate
a computationally e cient pipeline to estimate parameters for time courses with many
genes, see Section 3.3.3 for further details. It is a very strong assumption and apart
from the noise that is prevalent in most biological systems gene expression also changes
within a state due to cell internal mechanisms e.g. the cell cycle. The slightly more
relaxed but su cient assumption here is: Temporal changes within a state should be
much smaller than the di↵erence between biologically distinct states for genes influential
in such a transition. This case is illustrated in Figure 3.2(a) and 3.2(b). Therefore, this
is still a good first approximation in the case of transition processes.
A second assumption relates to the topology of the Markov chain. To ensure
parameter identifiability (see Discussion Section 3.2.2) we have to restrict the latent
process to a linear pure birth process. This restricts the topology of the Markov chain
quite drastically, but is arguably defensible when applied to externally driven transition
processes such as the ones discussed in this thesis. The external drive can take many
37
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(d) Gene not influential gradual change
Figure 3.2: The gene expression and time here are on an arbitrary scale as these plots
just serve as an illustration, to further simplify the point we only visualise
one gene. These are not actual measurements but rather constructed by
the author. The first assumption made is that gene expression remains
constant for a gene while the cell remains inside a state. The model in
Section 3.2.1 describes the single-cell measurements of cells transitioning
between states as an instantaneous step change (red line). In reality, the
measurement will at least fluctuate and transition won’t be instantaneous.
For influential genes illustrated in (a) - (b), this assumptions is reasonable
whether or not the transition is instantaneous, the points here are meant
to represent single measurements of genes. For genes where within a state
temporal changes are comparable to changes between states, (c) - (d),
the approximation is not good. These genes are not influential for the
transition process as their expression does not change therefore this is not
problematic.
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di↵erent forms; in the two examples we investigate the system is driven by genetic
induction. Of course back transitions are likely, for such cases our model is mis-specified
and the forward transitions rates are only e↵ective values where the back transition rates
have been absorbed into the model. Consequently, estimated forward transition rates
are lower than the real values. On occasion back transitions or topologies of the latent
process are of interest. The likelihood eqn. (3.2) is general and does not make any
assumptions about the topology of the Markov chain, but additional data or constraints
would be required for identifiability of more complex transition topologies. Often the
limiting factor is available data hence we focus here on the more useful but special case
where only time-course data is available and the latent stochastic process is a linear birth
process. In Section 3.4 we include a detailed investigation into the impact of breaking
this assumption in a simulation.
Finally, we assume rates of cell death and cell duplication cancel each other
out and the population therefore remains roughly constant in time. Consequently, the
fraction of cells in a given state only depends on the transition rates between the states.
Especially in the case of oncogenic transformation (Chapter 4) this is clearly not the
case since tumorous cells in general have a much higher proliferation rate. In Section
3.4 we test how well parameters are estimated when this assumption is violated.
3.2.2 Identifiability
Parameter identifiability is a very important concept in STAMM since parameters rep-
resent physical properties of cells. A result for the identifiability of such a model with a
discrete time latent process was presented by Cli↵ord [1977]. Unfortunately, there does
not exist a conclusive result on identifiability for latent stochastic model with a contin-
uous time latent process. To establish if STAMM is identifiable analytically is highly
non-trivial, therefore we perform tests for empirical identifiability using single-cell sim-
ulations in Section 3.5.1.
3.3 Estimation
The discussion in this section is motivated by work published in Armond et al. [2014], but
the model selection procedure does not follow the same heuristic or Bayesian approach
but has been updated. Additionally some of the details of parameter estimation have
also been changed to streamline the procedure and make it computationally e cient.
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3.3.1 Parameter estimation
We begin by stating the maximum likelihood estimates (MLEs) based on the likelihood
eqn. (3.2)
({ ˆj}, wˆ) = argmin
{ j},w
pX
j=1
TX
t=1
kg(xj(t))  g
 
p(t|w) j
 k22, (3.6)
where k·kq denotes the `q norm with respect to its argument. The transformation g is in
general non-linear as discussed above (e.g. log in microarrays or arcsinh in RNA-seq), for
such transformations the MLE (3.6) cannot be obtained in closed form. Genome wide
measurements yield readings with number of genes, p, of up to 104. Directly optimising
eqn. (3.6) is not practical for a problem with large p as the parameter space is a function
of the number of states and p. We adopt a two-step estimation procedure proposed by
Armond et al. [2014]. The first step is based on the observation that many genes have
similarities in their measured time-courses; this allows us to cluster genes obtaining m
clusters describing typical temporal patterns. Details for choosing the parameter m are
discussed in Section 3.3.3. The m cluster centroids are used to estimate the transition
rates w via eqn. (3.6), instead of all genes. This approach reduces computation time
significantly when m << p. The transition rates estimated using cluster centroids, wˆ,
are fixed and the   values for all remaining genes are estimated. The MLE is now written
as:
 ˆj = argmin
 j
TX
t=1
kg(xj(t))  g
 
p(t|wˆ) j
 k22 +  k jk1 (3.7)
where the final term is an (optional) `1 penalty with tuning parameter  . It is invoked
when potential over-fitting needs to be counteracted (choice of   is discussed in Section
3.3.3).
The optimisation eqn. (3.7) greatly simplifies estimation (compared to eqn.
(3.6)), since estimation for individual  j for gene j can be performed independently.
This is possible because time-courses between individual genes are only coupled by
transition rates w; once they are fixed, individual gene trajectories can be examined
independently.
3.3.2 Model selection
The estimation steps described in Section 3.3.1 apply to a model with a fixed number
of states K. Here we present a procedure to determine the number of states K that
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best represent a data set under investigation. Depending on the application K itself
can be of scientific interest. In general estimated state-specific expression signatures,  ,
are influenced by the number of states. Underestimating in number of states results in
distinct states being merged. Overestimating the number of states introduces artificial
states in the transformation. Both scenarios lead to poor estimation of parameters.
In general model selection can be performed using a form of cross-validation (CV)
by leaving out part of the data as a validation set. In the applications we consider usually
there is only one sample therefore we have to perform CV by leaving out time points.
In some cases it is also possible to use BIC e.g. when the number of genes is small,
but this quickly breaks down as the number of genes p increases, as can be seen in eqn.
(2.14). For large p the second term would completely dominate the BIC term; therefore
we restrict ourselves to CV. In applications to time-series, cross-validation is often non-
trivial due to discrete and irregularly spaced observations. The STAMM model has an
underlying continuous-time latent process, which allows for prediction of any time points
from estimated parameters; therefore comparison between predicted time-points, from
estimated parameters, and the corresponding held-out data can be performed without
any problems. In this application due to poor time resolution it is often not possible to
include more than one time point in the validation data; this variant is called leave-one-
out cross-validation (LOOCV). In this LOOCV we do not use the first time point in the
validation set as the model assumes that initially all cells occupy the same state which
is only assured at the first time point. If t is the held-out time point let the estimated
parameters for the remaining subset be rates wˆ t, state specific expression { ˆ tj } and
gene-specific standard deviation { ˆ tj }. State occupation probabilities at the held-out
time point p(t|wˆ( t)) are obtained by solving the master equation using estimates derived
from the training data. There we can now write a prediction for the expression of gene
j at the held-out time point xˆCVj (t) = p(t|wˆ( t))  ˆ
( t)
j and the cross-validation mean
squared error (MSECV the units of which are dependent on the transformation g(xj(t))
and the units of xj(t)) is simply
MSECV =
TX
t=2
pX
j=1
1
 ˆ( t)j
 
g(xˆCVj (t))  g(xj(t))
 2
. (3.8)
The strength of this type of model selection in comparison to the Bayesian ap-
proach presented in Armond et al. [2014] is twofold. Firstly application of the com-
putationally e cient estimation procedure outlined in Section 3.3.1, allows this cross-
validation procedure to be applied to the whole data set e ciently. Secondly, it doesn’t
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Figure 3.3: Schematic of estimation pipeline. Clustering of normalised gene trajecto-
ries provides an optimum number of clusters mˆ, the centroids of the clusters
summarise typical trajectories contained in data. Fitting the model to cen-
troids we can find transition rates w. Stability of estimate test is performed
to determine the need for penalisation of model parameters with strength
 . State-specific gene expression signatures  kj are estimated by varying
the number of states in the model K and   (if applicable). Optimum
number of states are determined by performing a form of cross-validation.
Finally sensitivity of estimation to change in mˆ is performed. If necessary
the pipeline is rerun with a better choice of mˆ.
require parameters to be set by the user except those required for estimation. The
Bayesian approach requires a computationally demanding Monte Carlo estimation and
has several hyper-parameters, which have to be set by the user.
3.3.3 Estimation pipeline
We now present a computationally e cient pipeline for setting tuning parameters re-
quired for estimation. The pipeline is also summarised in Figure 3.3. The required
tuning parameters are:
⌅ The number of clusters: m, used in the first step of the two-step estimation.
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⌅ The strength of the penalty term,  , applied in eqn. (3.7), where   = 0 is equivalent
to no penalty.
⌅ The number of states in the latent Markov chain, K.
Number of cluster: In the initial estimation step we cluster gene expression tra-
jectories which results in cluster centroids describing typical trajectories; these permit
estimation of transition rates. In empirical results (see Section 3.5.2) we see; if the num-
ber of clusters is large enough to capture most of the information in typical trajectories
changing m does not have a significant impact on parameter estimation. Therefore, we
set m using a simple k-means algorithm and inspecting the relative decrease of within-
cluster sum of squares objective J(m) as a function of m:
 J(m) =
J(m  1)  J(m)
J(m  1)
We select mˆ such that mˆ = min{m :  J(m 1) < 0.1}, i.e. if the relative decrease
in the objective function is smaller than 0.1 for m   1 we choose m as the number of
clusters. Small fluctuations in the objective function for higher m lead to instabilities in
the relative decrease. Once mˆ is set we include a post-estimation sensitivity test for the
choice of m. In section 3.5.2 we demonstrate with the help of empirical results, how well
behaved and computationally e cient this model is. Though it should be noted that the
choice of m can be made with any clustering method and the corresponding objective
function.
Penalisation: The penalty term introduced in eqn. (3.7) is useful in high dimensional
models; even though the data investigated using this model will often be high dimen-
sional, estimation is carried out separately for each gene. Therefore, penalisation may
not be required unless the number of time points is large. Consequently, we introduce
an additional step to test the need for penalisation by comparing estimated expression
signatures   with estimates obtained from leaving out individual time points. We specify
stability as a Pearson correlation between estimated   values greater than 0.8. The Pear-
son correlation (a dimensionless quantity) between two populations a and b is calculated
as
⇢(a, b) =
cov(a, b)
 a b
=
E[(a  µa)(b  µb)]
 a b
If we deem a data set stable under such a test there is no need for penalisation
and we choose   = 0. If the Pearson correlation is smaller than 0.8 a penalty term
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is required (setting the penalty strength is discussed below). In both the simulated
data sets and application to oncogenic transformation penalisation was not required and
  = 0 in Sections 3.5 and 4.
Number of states: The final parameter to be set is the number of states in the latent
Markov chain. This parameter is set by minimising the CV score (MSECV) for a range
of di↵erent K. If penalisation is required MSECV is minimised by performing a grid
search over both   and K.
All three parameters (m,  , K) can in principle be set by performing a grid search
with respect to MSECV, but this is computationally very challenging and would make
estimation impractical. Our pipeline makes use of heuristic observations to reduce the
grid search to one dimension. The observation that estimates are robust to changing
the number of clusters used in the first step, allows us to remove m from the grid
search. Observing that the penalty term is not always needed enables us to exclude
  from the grid search. When choosing m using a clustering method it could be that
transition rates haven’t converged. Therefore, we carry out an additional diagnostic
post estimation. The issue we are trying to address is that an increase in m corresponds
to an increase in information; this can lead to changes in estimated parameters. If
the choice of parameters is appropriate increasing the number of clusters should not
significantly impact estimated parameters. To this end we compute Pearson correlation
values between expression levels   estimated using mˆ clusters and estimated using larger
values m0 > mˆ. Provided results have Pearson correlation above 0.8, the choice of mˆ was
appropriate, if the Pearson correlation is below 0.8 we repeat the pipeline with larger m.
3.4 Simulation setup
To test the validity of the model we need to test it with simulated data where true
parameters are known. This will allow both evaluation of strengths and weaknesses
in parameter estimation and model selection (choosing number of states). Simulations
are performed not at the cell population level of the likelihood eqn. (3.2) but at the
single-cell level; allowing for extensive testing of model assumptions. The single-cell
trajectories are then averaged to obtain homogeneity data analogous to RNA-seq data.
Here we describe the step-by-step simulation procedure for a K state model
independent of the number of genes simulated:
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Figure 3.4: Simulation study. State occupation probabilities for a four state model
with transition rates [1/5, 1/8, 1/15]. The transition rates are set to these
values for all simulations, the values are chosen to allow k = 4 to have a
high occupation probability at the final time-point of the simulation.
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State transitions. When setting transition rates between discrete states of the Markov
chain we need to keep a few things in mind. Firstly, the smallest sampled (observed in
real data) time step needs to be smaller than the transition time between states. Just like
in typical experimental designs for transition processes. Additionally the model, won’t
be able to extract information about a process taking place on a time-scale smaller than
gaps between observations. Secondly, we are considering transitions processes driven
towards an established final state (e.g. oncogenic transformation, pluripotency); so to
mimic this behaviour in simulated data we need to insure the occupation probability for
the final state is higher than for other states at the final time point. Of course in realistic
experiments even at the final time point the cell population will still be heterogeneous In
the discussion that follows in Section 3.5 we use the three transition rates [1/5, 1/8, 1/15]
for four state model. In Figure 3.4 we show the state occupation probabilities for these
parameters and k = 4 has an occupation probability of ⇡ 0.89 at the final time point.
For every cell in the simulation, state transitions are simulated by drawing jump-times
from an exponential distribution with parameters given by transition rates as defined
for a continuous-time Markov chain.
State-specific expression levels. For all cells, each gene j and state k we set gene
expression levels  kj . For each gene we set expression levels to zero with probability
1/K, otherwise they are sampled uniformly from (0,  j ]. Parameter  j , chosen from the
range [1, . . . , 12000], e↵ectively sets the scale of gene j 1. This method ensures simu-
lated trajectories for genes on di↵erent scales (see Figure 3.5(a) and the corresponding
gene expression signatures Figure 3.5(b)), to emulate real RNA-seq data where a range
of five order of magnitude was observed [Wang et al., 2009; Mortazavi et al., 2008].
Gene expression trajectories for single-cells are piecewise flat for each gene once   val-
ues are sampled. Changes in trajectories only occur at jumps between states and are
instantaneous.
Aggregation and time-sampling. For each gene j each cell has an associated gene
expression trajectory. Similar to RNA-seq experiments where observations are averages
of gene expressions over many cells; these trajectories are averaged over a large number
of cells to give an average gene expression trajectory. The occupation probability in the
model outlined in Section 3.2.1 is derived in the limit of number of cells !1, of course
in practice the number of cells is finite. We set the number of cells to 1000 which serves
1It is always chosen from the following  j = {1 , 10 , 50 , 100 , 200 , 500 , 1000 , 2000 , 4000 , 7000 ,
10000 , 12000}
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as a good test of the limiting assumption.
The simulated time-course is obtained by sampling the simulated trajectories
at discrete unevenly distributed time points. Finally Gaussian noise is added to the
transformed data (see Section 3.2.1 for details, for RNA-seq arcsinh) with mean zero
and standard deviation  ; which we set to   = 0.2 unless states otherwise, this pro-
vides a reasonable signal to noise ratio for all observations. Similar to the RNA-
seq data discussed in Chapter 4 we choose 15 unevenly spaced time points at t =
{0, 2, 4, 7, 8, 11, 14, 20, 24, 29, 32, 35, 40, 44, 48}. The simulation setup is summarised in
pseudocode in Algorithm 1.
Algorithm 1 Pseudocode for single-cell simulations
procedure Simulation(n.states, n.genes, n.cells, r, p,w, dt,  )
   unif(0,  )
jump.t Exp(wk 1,k)
for all genes, cells do
for t 0, T do
for states 1,K do
while t < jump.tstates do
sim.traject(t)  j,k
end while
end for
end for
end for
average sim.traject per gene for all cells
sim.data sim.traject (sampled at discrete time)
sim.data sim.data + N (0, )
end procedure
3.5 Simulation results
We present results from simulations in two separate phases. For both simulation setup
the transition rates are fixed at [1/5, 1/8, 1/15] and we simulate from a model with four
states in latent Markov chain. First in a small-scale simulation with p = 9 genes we
perform multiple rounds of direct estimation of the whole data without the need for
the initial clustering step. This simpler simulation allows investigation of identifiability
and an investigation for model selection without considering the two-step estimation
procedure outlined above.
Then we consider a larger scale simulation with p = 120 genes, where we put the
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full two-step estimation procedure to the test— including clustering, setting of tuning
parameters and finally model selection.
3.5.1 Small-scale simulation
Using the small-scale simulation we perform three separate tests. One in which we only
estimate transition rates and state-specific expression levels; we consider the number
of states to be known. Then we consider the model selection problem and finally we
investigate estimation under breaking model assumptions.
Number of states known
We simulated 9 genes from a 4 state model as described in Section 3.4. In this small
simulation we do not use a penalisation term, i.e.   = 0. In Figure 3.5(a) we show
trajectories for one such realisation, here the thicker line represents trajectories from
averaging 1000 cells. The green dots show sampled data with the addition of Gaussian
noise to transformed data. The gene expression is labelled as counts per gene [cpg]
since the simulation is modelled after RNA-seq measurements, but since it is only a
simulation this a choice. The time is arbitrary as the simulation does not depend on the
unit of time. In Figure 3.5(b) we show state-specific gene expression signatures for all
9 simulations. The values are shown in pairs of true and estimated. The value on the
right is in each case the true value used in simulating the trajectories. The left-hand
value is the parameter estimated by fitting the 15 time points from the simulation time
course. The corresponding estimated and true transition rates for this realisation can
be seen in Table 3.1. Using the estimated transition rates and the expression signatures
we can obtain an estimated trajectory, seen as a blue line in Figure 3.5(a).
Transition rates w1,2 w2,3 w3,4
true mean 0.200 0.125 0.067
estimated 0.236 0.114 0.068
Table 3.1: Transition rates used in the simulation and the estimated values
We repeat fifty such independent simulations at four di↵erent noise levels 2, each
time  kj are resampled as described above (Section 3.4) while transition rates are shared
across simulations. We compute the Pearson correlation between estimated and true
gene expression signatures for each simulation run ⇢( ,  ˆ). The Pearson correlation co-
e cients for all simulations are summarised in a boxplot, Figure 3.6(a). For all tested
2  = {0.05, 0.1, 0.15, 0.2}d
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(a) Simulated Trajectories for p = 9
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(b) Expression signatures for p = 9 simulation
Figure 3.5: Simulation study. Small scale simulation for p = 9 genes. (a) shows the
trajectories for these simulations, the gene expression is plotted as counts
per gene [cpg] and the time is in arbitrary units. The thick red line shows
the averaged trajectories over 1000 cells. The green dots show 15 sampled
data points with normal noise (N (0, ), with   = 0.2) added to the average
data. The blue thin line shows the trajectory from estimated parameters.
(b) shows state-specific gene expression signatures as counts per gene [cpg]
for all 9 simulated genes. The true and estimated parameter values are
shown next to each other. The lighter colour on the left shows estimated
parameter values, the solid colours show true parameter values.
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(b) Transition rates
Figure 3.6: Simulation study. Small scale simulation using p = 9 genes with 50 inde-
pendent repeats. Boxplots show results over all repeated simulations at
four di↵erent noise level   = {0.05, 0.1, 0.15, 0.2}. (a) Boxplots for Pear-
son correlations between estimated and true gene expression signatures
(⇢( true,  ˆ) a dimensionless quantity) at four di↵erent noise levels. (b)
Boxplots for the mean of absolute di↵erences between the estimated and
true transition rates s¯ (with units 1 / time which in this simulation can be
anything) for each simulation at four di↵erent noise levels.
noise levels we compute a mean and standard deviation of the Pearson correlation coef-
ficient across all fifty runs in Table 3.2; The mean is above 0.9 for all simulations and
the highest level for the variance is 0.13. Therefore, we can conclude that state-specific
gene expression signatures are recovered well in the simulation. We also introduce a new
measure, sk = |wˆk,k+1 wk,k+1| to test recovery of transition rates. For each simulation
we use the mean s¯ over the three transition rates as measure for how well transition
rates are recovered. In Figure 3.6(b) we show boxplots for the fifty simulations for each
of the four noise levels. We find that transition rates are also recovered well, though as
expected the estimates become worse with increasing noise levels.
  0.05 0.1 0.15 0.2
mean 0.95 0.93 0.94 0.91
std. dev. 0.07 0.09 0.08 0.13
Table 3.2: Pearson correlation between true and estimated gene expression signatures.
Mean and standard deviation are estimated across 50 independent simula-
tions.
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Determine number of states
Next, we consider the problem of model selection in this small simulation setup. We
simulate data as described above for p = 9 genes. In such a model with a latent stochas-
tic process, model selection is a challenging problem especially using noisy data sets.
Therefore to test model selection we perform fifty independent simulations for the fol-
lowing noise regimes:   = {0.05, 0.1, 0.15, 0.2}. We compare models with K = 1, . . . , 5
and perform model selection using leave-one-out cross-validation (see Section 3.3.2), for
each of the fifty simulations. We determine the minimal MSECV scores (eqn. (3.8)) for
di↵erent models and juxtapose a comparison between the di↵erent models using a simple
normalised MSE score for model fit without held-out time points. In each simulation and
for each noise regime we determine the model with lowest MSECV score and lowest MSE
score. Then we show the distribution of these minimal scores over the selected number
of states in Figure 3.7; the top row shows the distribution for MSECV and bottom row
show the distribution for MSE in di↵erent noise regimes.
Here number of parameters increase with number of states, and as a result model
fit improves; therefore as expected at all noise levels the maximum number of states
(K = 5) results in the best fit.
Violating model assumptions
Until now, we have considered simulations with a correctly specified model where as-
sumptions underlying the model are not violated. Breaking these assumptions is es-
pecially easy in the single-cell simulation. We investigate consequences on parameter
estimation under violation of a subset of these assumptions. We use three types of plots
to investigate parameter estimation for these simulations.
⌅ Correlation. For state specific gene expression signatures  kj we compute the
Pearson correlation coe cient between true parameters and estimated parameters,
⇢( true,  ˆ).
⌅ Transition times. We show boxplots of estimated average transition times for
10 simulations and a horizontal dashed line to represent the true value used in the
forward simulation.
⌅ Probability In the model itself the transition times do not enter directly they
are used to calculate probabilities. We compare the values by calculating a mean
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Figure 3.7: Simulation study. We perform fifty independent small-scale simulation
with p = 9 at four di↵erent noise levels   = {0.05, 0.1, 0.15, 0.2} for K = 4.
We perform model selection using a form of cross-validation and find the
state K that minimises the MSECV score, top row. As a comparison we
also show fit to data and find the state K that minimises MSE. We find
that even at very high noise levels using MSECV it is possible to identify
the right model. An example trajectory and parameters can be seen in
Figure 3.5.
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di↵erence between probabilities:
h|pˆk(t)  pk(t)|ik,t , (3.9)
where k is the number of states, pˆk(t) is the probability calculated from estimated
parameters and pk(t) is the probability calculated from true values. The average
is taken over both the states and time.
Cell death and cell doubling An assumption implicit in STAMM is that cell death
and cell duplication happens at a constant rate across all states in the transformation
process. This is of course not the case in the discussed example of oncogenic transfor-
mation, since transformed tumorous cells have a much higher proliferation rate than the
initially healthy cells. In the single-cell simulation setup we sample a time of death, tdi ,
and a time for cell doubling, tdupi , from an exponential distribution. If sampled rates
for a cell are outside of the time range of the simulation, the cell remains unchanged.
If they are both in the range, there are two possible scenarios. Firstly if the death
rate is the smaller of the two, cell i is taken out of the simulation t > tdi . Secondly if
tdupi < t
d
i , cell i is taken out of the simulation at t > t
dup
i and two new cells are simulated
with new sampled state transitions. The simulation and estimate is performed 10 times.
Investigating the oncogenic transformation discussed in the paper it was observed that
generally cells have a doubling rate of close to 0.05 i.e. doubling of cells occurs roughly
every 20 hours. In Figure 3.8 we fix the doubling rate and since cells in this experiment
rarely die, we choose very small death rates. 3.8a) shows the average as a dark line
and the shaded area represents the standard deviation for the 10 repeated simulations.
3.8b) shows boxplots for the estimated average transition times. 3.8c) shows the mean
di↵erences between estimated and true probabilities averaged over 10 trajectories as a
solid line and the shaded area represents the standard deviation.
In Figure A.1 we include additional cell doubling rates. In general, gene expres-
sion signatures are estimated well, but the transition rates are not. During estimation,
transition rates only enter as probabilities hence badly estimated transition rates don’t
have a significant negative e↵ect on the estimation of expression signatures. To see what
e↵ect the di↵erent parameters have on the number of cells simulated at any given time
Figure 3.9 shows the number of cells as a function of time for di↵erent cell death and
cell doubling rates.
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Figure 3.8: Simulation study. Testing assumption about cell death and cell doubling.
For each cell a time of death, tdi , and a time for cell doubling, t
dup
i , is
sampled from an exponential distribution with varying average rates. If
the sampled rates for a cell are outside of the time range of the simulation,
the cell remains unchanged. If they are both in the range there are two
options. The first option is that the death rate is the smaller of the two in
that case the cell i is taken out of the simulation t > tdi . If t
dup
i < t
d
i , cell i
is taken out of the simulation at t > tdupi and two new cells are simulated
with new state transitions. The simulation and fit is performed 10 times.
In experiments, we observe cell doubling time to be roughly 20 hours and
very few dead cells. Therefore the simulation is performed with a cell
doubling rate of 0.05 and a variety of death rates. a) shows the average
as a dark line and the shaded area represents the standard deviation for
the 10 repeated simulations. b) shows box plots for the estimated average
transition times. c) shows the mean di↵erences between estimated and true
probabilities averaged over 10 trajectories as a solid line and the shaded
area represents the standard deviation.
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Figure 3.9: Simulation study. Testing assumptions about cell death and cell doubling.
Plots show number of cells at di↵erent time during the simulation for one
of the 10 simulations as a function of time which is shown in arbitrary
units. Each panel represents di↵erent death rates and each colour di↵erent
doubling rates.
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Figure 3.10: Simulation study. To test the a↵ect of back transition on the estima-
tion, we simulate trajectories with back transition at k = 4 with di↵erent
transition times. a) we plot the average Pearson correlation for 10 inde-
pendent runs, between true and estimated  kj parameters for di↵erent
average time for the back transition as a solid line. The shaded area
shows the standard deviation. The vertical dashed red line shows the
average forward transition time for k = 3. b) shows boxplots for the av-
erage transition rate estimated from the model for a system with K = 4
and only forward transitions. c) shows the mean di↵erences between esti-
mated and true probabilities averaged over 10 trajectories as a solid line
and the shaded area represents the standard deviation.
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Back transitions The second assumption we test is the inclusion of back transitions
in the single-cell. We simulate trajectories with back transition from k = 4 to k = 3;
they are sampled from exponential distributions with di↵erent means. In Figure 3.10
we show comparisons between estimated and true values of parameters as a function of
the average back transition time from state k = 4. 3.10a) we plot the average Pearson
correlation for 10 independent runs, between true and estimated  kj parameters as a
solid line. The shaded area shows the standard deviation. The vertical dashed red
line shows the average forward transition time for k = 3. 3.10b) shows boxplots for
the average transition rate estimated from the model for a system with K = 4 and
only forward transitions. 3.10c) shows the mean di↵erences between estimated and true
probabilities averaged over 10 trajectories as a solid line and the shaded area represents
the standard deviation.
Markovian assumption Finally, in this section we investigate the latent Markov
process and consider a case where jumps are non-Markovian. We want to consider the
more realistic case that the transition time is fat tailed; therefore we choose a truncated
Student t-distribution with a variety since transition rates are positive. We sample using
the tmvtnorm package in R with degrees of freedom, df , as the varied parameter. We
perform the simulation as before, but sample transition rates from the t-distribution
with means (1/5, 1/8, 1/15) and consider a range of df parameters in tmvtnorm. The
results are shown in Figure 3.11; 3.11a) shows the mean Pearson correlation between true
and estimated  kj as a solid line and the shaded area constrains the standard deviation.
3.11b) shows boxplots for the average transition rate estimated from the model for a
system with K = 4 and only forward transitions. 3.11c) shows the mean di↵erences
between estimated and true probabilities averaged over 10 trajectories as a solid line
and the shaded area represents the standard deviation.
3.5.2 Large-scale simulation
Lastly we want to check how well the two-step estimation pipeline outlined in Section
3.3.3 works applied to simulated data. We simulate p = 120 genes as described above
with K = 4 states. To mirror real data where genes are on di↵erent scales, we sample
12 scale parameters  . To get to p = 120 genes for each scale parameter, we sample
10 sets of   values. All other parameters are as set out in Section 3.4. We follow the
procedure set out above and start by clustering simulated trajectories into m clusters.
Then we estimate transition rates w from cluster centroids and keep them fixed for the
57
●
●
● ●
●
● ● ● ●
●
0.0
0.3
0.6
0.9
5 10 15 20
GIWïGLVWrLbXWLRQ
l
(`
,`
)
0
5
10
15
0
5
10
15
0
5
10
15
2 4 6 8 10 12 14
GIWïGLVWrLbXWLRQ
av
er
ag
e 
tra
ns
iti
on
 ti
m
e
w12
w23
w34
● ● ●
● ● ●
● ● ●
●
0.0
0.2
0.4
5 10 15 20
GIWïGLVWrLbXWLRQ
>D
UE
LWU
DU
\
XQ
LWV
@
a) b)
c)
>G
LP
HQ
VL
RQ
OH
VV
@
Figure 3.11: Simulation study. We simulate from a non-Markovian system, one where
average transition rates are heavy tailed. Here we sample from a trun-
cated Student t-distribution using the tmvtnorm package in R. It is trun-
cated at zero since transition rates are always positive. The transition
rates are sampled to have means (1/5, 1/8, 1/15) and we vary the degrees
of freedom df parameter in the package used. a) we show the average
Pearson correlation between true and estimated  kj , the mean is shown
as a solid line and the standard deviation as a shaded area. b) shows box-
plots for the for the average transition time estimated from the model for
a system with K = 4 states. c) shows the mean di↵erences between esti-
mated and true state occupation probabilities averaged over 10 trajecto-
ries as a solid line and the shaded area represents the standard deviation.
We only simulate a very small number of repeats for each parameter set
therefore the non-monotone behaviour of the error is not surprising.
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(a) k-means clustering
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Figure 3.12: Large-scale simulation study. Results from clustering. (a) Initial step
in the estimation pipeline is use k-means clustering for p = 120 genes.
The plot shows relative change in the k-means objective function as a
function of the number of clusters:  J(m) = 1   J(m)/J(m   1). We
choose the optimum number of clusters mˆ such that  J(m   1) < 0.1;
here mˆ = 13. For larger m, J(m) is small therefore relative changes have
large fluctuations. (b) Estimated transition rates as a function of the
number of cluster. Horizontal dashed lines show true values. After large
initial fluctuations, the transition rates fluctuate around the true value.
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Figure 3.13: Large-scale simulation. Stability of estimated expression signatures under
time point deletion to determine need for `1 penalization. We conclude
that estimated parameters are stable with a Pearson correlation > 0.8,
therefore there is no need for a penalty.
second step. Next we use these transition rates and estimate expression signatures  j
independently for each gene j.
Number of states
Applying the first step, we cluster the simulated data using a k-means clustering algo-
rithm. We use the relative decrease in the objective function  J(m) to determine the
number of clusters and vary m in the range [2, 30], see Figure 3.12. The relative decrease
is smaller than 0.1 for m = 12 therefore we choose mˆ = 13. Note that for larger m the
objective function J(m) is small and we observe that  J(m) has large fluctuations due
to slight deviations in the objective function. Then we test if for this set of data penali-
sation is necessary using stability of estimated gene expression signatures under deletion
of time points. Figure 3.13 shows that for all deletions estimated parameters are stable,
therefore we conclude that there is no need for a penalty term. Then we perform a
model selection step to determine the number of states K of the latent Markov chain.
We compute the MSECV score for K = {2, . . . , 5} states, see Figure 3.14(a); we see a
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Figure 3.14: Large-scale simulation. Simulation performed for p = 150 genes, 15 time
points and K = 4. Figures summarise results obtained from applying the
estimation pipeline (see Section 3.3.3) to the simulated data. (a) MSECV
score to determine optimal number of states in the model, the minimum is
atK = 4. (b) Test to determine stability under perturbation of number of
clusters mˆ is performed by examining the Pearson correlation. Estimation
is stable therefore the choice of parameters is reasonable. (c) To determine
dependence on structure of data we perform a permutation test, first by
permuting time-points of all trajectories in a coordinated fashion and then
by permuting trajectories independently. The MSECV score for permuted
data is significantly higher for all K other than K = 1 and data permuted
in a coordinated fashion perform better than independently permuted
data.
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clear minimum for K = 4 which is also the correct number of states. In the final step of
the pipeline we perform a post-estimation stability test to ensure the number of clusters
chosen is not too small (see Section 3.3.3). We compute the Pearson correlation for
expression parameters estimated with increasing number of clusters, see Figure 3.14(b).
We carry out this test for all models K = {2, . . . , 5} and the estimated parameters are
stable therefore we conclude that the choice of mˆ was a reasonable choice.
A question that arises from these results is to what extent they are indicative of
estimation if states are only estimated because the model assumes there are states in
data. One good way of addressing this question is to permute data and compare MSECV
estimated for permuted data and the original data. Here we distinguish between two
ways of permuting data: first, we perform a coordinated permutation where all simulated
trajectories are permuted in the same way. Then we perform a permutation for each
trajectory independently. In Figure 3.14(c) we show the results and we can see that with
both types of permutations the MSECV values are significantly larger than the original
data set.
Estimated parameters
One of the strengths of using simulated data is that we can compare estimated and true
parameters. Figure 3.15 shows a scatter plot of estimated   parameters against their
true values used in the simulation. The parameters are in general well estimated with a
Pearson correlation of 0.95; as the plot (Figure 3.15) shows in certain cases, despite the
large Pearson correlation, the true value of   is exactly zero but estimates are non-zero.
The first clustering step we take is crucial and has a considerable e↵ect on pa-
rameter estimation of transition rates. Hence, it is valuable to delve a bit deeper into the
first estimation step and its sensitivity to the number of clusters. Figure 3.14(b) shows
that estimated expression signatures are very stable when increasing number of clusters,
which is an important indicator of how well the the number of clusters is chosen. Figure
3.12(b) shows the three transition rates for a model with K = 4 as a function of m. The
horizontal dashed lines in the plot show true transition rates. We observe that estimated
transition rates strongly fluctuate for small m and with increasing number of clusters
amplitude of fluctuations decrease.
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Figure 3.15: Large scale simulation. Estimated gene expression signatures scattered
against their true values. To distinguish gene expression signatures for
120 di↵erent genes we represent them in di↵erent colours. Each distinct
colour represents parameters for one gene.
3.6 Discussion
We present an extension to previous work with a detailed description of the model in-
cluding its assumptions, an unbiased estimation pipeline and simulation based tests to
investigate STAMM recently proposed in Armond et al. [2014]. To address concerns
about practical application we have made computation more e cient including the use
of parallelisation which due the two-step estimation process allows for much higher ef-
ficiency; the exploration of model behaviour under violation of underlying assumptions;
and an extension to allow for application to RNA-seq data though more on that in
Chapter 4.
Establishing and investigating identifiability in a latent stochastic model aggre-
gate over single-cells is highly non-trivial. Some relevant literature exists [Kalbfleisch
et al., 1983; Kalbfleisch & Lawless, 1984, 1985], but it is applied to panel data or the
latent stochastic model is in discrete time. Identifiability results that can directly be
applied to STAMM do not exist yet. Therefore, we present empirical results using single-
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cell simulations and show that true parameters used during simulation can be identified.
However, it is important to understand and explore restrictions on Markov chain topol-
ogy; especially if there is potential for allowing more complex topology (e.g. including
branches or back transitions) by including additional single-cell data. This would allow
for precise experimental design in applications to ensure more details can be determined
about transformation processes.
To allow for e cient estimation and to ensure identifiability of model parameters
a number of simplifying assumptions are made in STAMM. Of course, these assumptions
do not hold in real biological systems. To investigate capabilities and limits of STAMM
we simulated data by breaking these assumptions in turn. In summary, we find the model
relatively robust under violations of underlying assumptions, but especially transition
rates under strong violations of the assumptions are estimated badly. This leads to
the conclusion that even though state-specific gene expression signatures are often well
estimated they should serve only as hypothesis to be confirmed by experiment.
STAMM is versatile in its application as it can be used for a broad range of
transition processes and data types. Two data types we investigate in this thesis are
microarray data and RNA-seq data but it can also be applied to transcript, protein
and epigenetic time course assays. New development of cheaper bulk assays means it
is a feasible first step to study a transforming biological system. In future STAMM
could be used to identify a subset of genes important in transformation; to pinpoint cell
surface markers that distinguish states facilitating a single-cell separation; or discovery
of transition to allow for targeted single-cell experiments. Using multiple types of data
in iterative stages would allow for a step-by-step improvement in information gathered
about the system. For instance once transition rates are known estimation of expression
signatures is much more precise and vice versa. In future it would also be interesting to
relax some of the assumptions made and extend the model to allow for back transitions
using experimentally verified forward transition rates.
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Chapter 4
Oncogenic transformation
4.1 Introduction
There are a variety of possible applications for the model outlined in Chapter 3; examples
include stem cell reprogramming [Armond et al., 2014] (contributions to which are dis-
cussed in Section 5) and estrogen response of breast cancer cell lines [Casale et al., 2013].
Another example is oncogenic transformation, which is the transition from healthy cells
to cancer cells, which we discuss in this Chapter. We consider a derivative of the hu-
man epithelial MCF10A cell line where the v-Src and estrogen receptor (ER) fusion is
integrated; the new cell line is called MCF10A-Er-Src [Hirsch et al., 2010] (for brevity
in the discussion that follows we will refere to these as MCF10A). The Src oncogene is
activated by addition of tamoxifen resulting in a rapid transformation of this system.
Morphological changes on a cellular level are observed as early as t = 24h (between
t = 24h   36h) they show the ability to form colonies in soft agar in the final trans-
formed state [Hirsch et al., 2010]. Figure 4.1 shows images taken of one realisation of the
experiment using a camera attached to a microscope; they are taken at t = {0, 24, 48}
hours at two di↵erent magnification levels (10x and 20x as indicated on the figure). The
top rows show images taken after induction of tamoxifen and morphological changes in
the cells can be observed. The bottom row shows images where no tamoxifen is added,
and as expected we don’t see any morphological changes just an increase in population
density. A comparison between the final two images of the two sets is especially revealing
as we can see cells elongated and overlapping cells in the induced system compared to
tightly packed smaller cells.
This is a very interesting system mainly because it consists of only a single per-
turbation, i.e. induction of the classical oncogene v-Src; leading to tumorigenesis and as
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Figure 4.1: During the in vitro oncogenic transformation of an MCF10A-Er-Src cell
line, morphological transformations can be observed between 24 36 hours
[Hirsch et al., 2010]. Here we show images taken of the experiment at
three di↵erent time points using a microscope without staining of cells.
The initial measurement at t = 0 hours and two subsequent measurements
at t = 24 and t = 48 hours. The magnification level for each image is
indicated in the figure. The top row shows images of the experiment where
Src is induced by addition of Tamoxifen at t = 0; the bottom row shows
images taken at the same time points without addition of Tamoxifen. It is
possible to see morphological changes at the final time point t = 48 where
after addition of Tamoxifen cells are elongated and overlapping compared
to the tightly packed structure in the system without induction. Sandra de
Vries in the Van Steensel Lab at the NKI, Amsterdam, took these images.
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such is a relatively clean setup to understand the process. Additionally it is an exception-
ally fast transformation (between t = 24   36 hours), which makes repeat experiments
to probe further properties of the systems for the verification of estimated parameters
easy to implement. The transformation also leads to morphological changes, which can
be observed under a microscope. Moreover, the initial state is a stable cell-line and
therefore tests or follow up experiments are easy to carry out.
In this Chapter we discuss one application of the two-step estimation pipeline of
STAMM (see Section 3.3.3). We investigate the oncogenic transformation of an MCF10A
cell line using data obtained by performing RNA-seq measurements. This experiment
was carried out especially for this work and the experimental design is summarised in
Section 4.2. In Section 4.3 we discuss pre-processing for RNA-seq starting from integer
count data to a time course to be used with STAMM. Then we present results obtained
from STAMM applied to the pre-processed data, in Section 4.4.
4.2 Experimental design
The data we analyse here was obtained by Sandra de Vries in the division of gene
regulation lead by Bas can Steensel at the Netherlands Cancer Institute (NKI). The
choice of time points was made taking the following criteria into account:
⌅ to facilitate a better understanding of the system using results from previous work
in Hirsch et al. [2010]
⌅ to have su cient data points to work well with STAMM
⌅ the cost of each RNA-seq measurement
The experiments were performed in MCF10A-Er-Src cells, a derivative of mam-
mary epithelial cell line MCF10A containing an integrated fusion of the v-Src oncoprotein
with the ligand binding domain of ER [Hirsch et al., 2010; Iliopoulos et al., 2009]. The
cells were cultured in DMEM/F12 medium supplemented as described in Debnath et al.
[2003]. There are two starting points and for both the medium is refreshed, then a
medium containing 1µM activating tamoxifen is added and the mixture is grown to a
80   85% confluency population, and induced and uninduced samples were harvested
at the time points 0h, 0.5h, 1h, 2h, 4h, 6h, 8h, 10h, 12h, 24h, 28h, 32h and 48h for
RNA isolation. The second series is started when the first one is at 8h and samples
are collected at 0h, 2h, 4h, 16h, 18h, 20h, 24h, and 40h. Time points are collected as
follows: wash with PBS; add 2ml Trizol resuspend thoroughly and store at  80 C. The
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tamoxifen stock was made by dissolving 5mg in 12.9ml 96%EtOH, to make 1mM stock.
We did not send all the samples to the microarray facility, only the following (due to
cost considerations):
1st series: 0h, 0.5h, 1h, 2h, 4h, 6h, 8h, 12h, 16h, 20h and 24h
2nd series: 0h, 24h, 32h, 40h and 48h
The RNA was isolated by the Trizol method, and prepared for sequencing by the Illumina
RNA TruSeq sample protocol.
4.3 Pre-processing data
As described in Section 2.3.2, RNAseq data obtained from samples results in integer
counts for genes corresponding to the number of times a sequenced strip belongs to
a particular gene. To ensure that we are able to compare samples from di↵erent ex-
periments in di↵erent setting the first step is normalisation. Many methods exist to
normalise sequencing experiments. We pre-process the data using the edgeR package
in R [McCarthy et al., 2012; Robinson et al., 2010]. One important assumption is that
most genes are not di↵erentially expressed between samples. To determine genes that are
not di↵erentially expressed the procedure uses a robust estimate for the ratio of RNA
between samples: the weighted trimmed mean of M values (TMM). Two parameters
are employed to filter out genes that are di↵erentially expressed namely: the M-values
(log-fold-changes) and the A-value (absolute expression levels). The cut-o↵ for both the
M-value and the A-value is tuneable and the best way to set the tuning parameters is to
select a range of cut-o↵ parameters and determine when they stabilise (see Appendix B).
It is important to remember that edgeR was developed to analyse di↵erential expression
[Robinson & Oshlack, 2010], still the assumptions are also applicable to time course data
such as the data set for the oncogenic transformation. Note without this step it is not
possible to compare data from di↵erent samples.
After the first pre-processing step we still can’t use the data in our model because
the likelihood is based on an additive Gaussian noise model (eqn. (3.2)). For RNA-seq
data, once it has been normalised, the next pre-processing step is to transform the data
such that distorting e↵ects at high expression values are reduced. We use a nonlinear
transform proposed by Ho↵man et al. [2012] the arcsinhx = ln(x +
p
(x2 + 1)). The
advantage of using this transformation over the more regularly used lnx is that it has
the same e↵ect of reducing variance at higher values but a much smaller e↵ect at lower
values. After applying these two pre-processing steps, we can use this data in our model.
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4.4 Results
The data obtained uses RNA-seq to examine changes in gene expression during this
transformation time-course with T = 13 time points1. According to the assumption in
our model all cells are in the initial state at t = 0. Here, by experimental design, the
initial state consists of the derivative MCF-10A-Er-Src cell line. More specifically the
time point t = 0 corresponds to the initial treatment with tamoxifen an anti-oestrogen
drug that binds to ER activating v-Src. Of course, this is only the case excluding any
unidentified epigenetic heterogeneity in the initial cell culture. Therefore, it is reasonable
to assume that the cell population is approximately homogeneous and comprised mainly
of untransformed MCF-10A cells.
We want to focus our investigation only on genes that change during the exper-
iment. To that end we define  j as the standard deviation of the time course for gene
j. We filter out all genes j where the standard deviation  j is too small, setting the
threshold at  j > 20 (on the linear scale, over time). We remain with p = 2809 gene
expression trajectories to which we apply STAMM. We carried out parameter estimation
as described in Section 3.3.3 using a two-step process. The initial step is to perform a
stability test, determining the need for a penalty term by comparing estimated expres-
sion signatures from the whole data set and one with left out time points. We conclude
from the results in Figure 4.2 that there is no need for a penalisation. The next step is
to cluster the data using k-means clustering where we want to use cluster centroids to
estimate transition rates in the next step. We conclude from Figure 4.3 that the optimal
number of cluster mˆ is 13. We use this result to perform model selection using cross-
validation for k = {1, . . . , 5}. We find that the MSECV score shows a minimum at K = 4
states (see Figure 4.4(a)). This would suggest two distinct intermediate states in the
oncogenic transformation of MCF-10A cells. Figure 4.5(a) shows a representative set of
trajectories from RNA-seq data in green and the blue lines shows predicted trajectories
using estimated parameters. Overall, we find that the model performed well and fits
even diverse trajectories well. State-specific gene expression signatures corresponding to
these trajectories are shown in Figure 4.5(b). These values show distinct patterns that
would allow for filtering out surface markers distinguishing states. The final step of the
estimation pipeline is to check sensitivity of estimation due to an increase in the number
of clusters m. This test is performed by computing the Pearson correlation between
expression signatures estimated using mˆ clusters and higher numbers of clusters. Figure
4.4(b) shows the Pearson correlations as a function of m for K = 3 and K = 4 and we
1t = {0, 0.5, 2, 4, 6, 8, 12, 16, 20, 24, 32, 40, 48h}, at t = 0 and t = 20 we have a repeated measurements
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Figure 4.2: The RNA-seq measurements are filtered with respect to standard deviation
(we filter out genes with  j > 20 before transformation) because we are
interested in genes that change significantly in time. This plot scatters es-
timated expression signatures using all time points against estimates where
one time point is dropped. This tests stability of estimates to determine
need for `1 penalisation under deletion of time points. The estimates are
stable (Pearson correlations is > 0.8 therefore we conclude that there is no
need for a penalty term.
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Figure 4.3: K-means clustering of in vitro data for the transformation of an MCF10A
cell line. Initial k-means clustering is performed to identify representative
trajectories. As described in Section 3.3.3 we choose the optimal num-
ber of clusters mˆ by considering relative changes in the objective func-
tion  J(m) = (J(m   1)   J(m))/J(m   1); we choose the first m with
 J(m 1) < 0.1. The plot shows  J as a function ofm and the horizontal
dashed line represents our threshold at 0.1. For this example we can see
that the mˆ = 13. Note that fluctuations in the value of  J at higher m
are due to small values of J(m).
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(b) Stability of number of cluster
Figure 4.4: MCF-10A data. (a) MSECV score as a function of K. The minimum at
K = 4 shows the optimal number of states for this oncogenic transfor-
mation. (b) To determine if the choice of mˆ in the k-means clustering
algorithm was chosen correctly a stability test is performed. Pearson cor-
relations are calculated between expression signatures estimated between
the mˆ used and larger m. Here we find the clustering is close to one for
K = 3 and K = 4 therefore the choice is reasonable.
find that the estimates are stable and therefore mˆ was chosen well.
This concludes the application of STAMM to the RNA-seq time course for an
oncogenic transformation. The example illustrates that the application of the model to
novel RNA-seq data can be carried out e ciently. However to investigate and validate
of the intermediate states further experiments are needed since the current time-course
is biologically not viable for further study (see discussion below) this has to be left as
future work.
4.5 Discussion
We applied our estimation pipeline (see Section 3.3.3) to time course data obtained by in
vitro experiments for oncogenic transformation of a MCF-10A cell line. The system has
many fascinating properties, the fact that it undergoes a rapid state transition between
phenotypically distinct states makes it a very useful system to study. Even though the
driver for the transformation is one of the most well studied oncogenes, there are still
many open questions about epigenetic and genetic changes during this process as well
as general oncogenic transformations. Note that due to a mycoplasm infection in the
cells used for the in vitro study substantive biological conclusions can be drawn only
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Figure 4.5: MCF-10A data. (a) The green line connects data points from measure-
ments on the oncogenic transformation of MCF-10A cell-line. The blue
line shows predicted trajectories from the model using estimated parame-
ters. We can see that the model fits the trajectories well since the data is
a single realisation of a noisy measurement. (b) The estimated  kj values
for the trajectories are plotted here as bar charts. We can see that there
are diverse expression signatures present in the data.
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with extreme caution. Additional experiments are needed to verify the validity of this
time-course data set.
The main goal of this application was to illustrate that STAMM can be applied
to RNA-seq data and can potentially provide useful results. However, in future due
to the clean and relatively rapid transformation in the system, it will very useful in
validating some claims from the model. It would also serve well as an example system,
to extend the model to include verification steps after an initial application followed
by application of a more detailed model. If it is possible to find surface markers that
allow us to distinguish specific states, it should also be possible to obtain more detailed
information on the latent process i.e. measure transition rates between states and maybe
include backward transition to obtain more precise estimates for state-specific expression
signatures.
Model selection for k = {2 . . . 5} and estimation for all parameters for the RNA-
seq dataset was performed after applying threshold on the expression count leaving us
with p = 2809 genes. Computation took 3.8 hours on 50 cores each with an AMD
2600MHz cpu.
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Chapter 5
Stem cell reprogramming
5.1 Introduction
Another application of the STAMM model is the description of reprogramming of so-
matic cells to a pluripotent state as investigated in Armond et al. [2014]. In the experi-
mental setup a secondary mouse embryonic fibroblasts (MEFs) is used and transformed
to a state of pluripotency [Takahashi & Yamanaka, 2006; Jaenisch & Young, 2008].
More specifically we apply the model to genome-wide microarray gene expression time-
course data obtained by Samavarchi-Tehrani et al. [2010]. This transformation system
has received a lot of attention and has been extensively studied in recent years; it has
been suggested that the reprogramming process is inherently stochastic [Hanna et al.,
2009]. Progress has also been made on single-cell investigations of the biological sys-
tem [Buganim et al., 2012]. Questions still remain on genome-wide level, including the
number of intermediate states between the initial MEF state and the final pluripotent
state.
In this Chapter we start by briefly outlining results obtained by Armond et al.
[2014] when applying STAMM to a microarray data set in Section 5.2. Then (in Section
5.3) we discuss the main contribution in detail which is a comparative study of param-
eters obtained from STAMM and single-cell experiments performed by Buganim et al.
[2012]. The single-cell data was obtained by a new kind of experimental technique called
a Fluidigm assay. This also illustrates an example of a possible next step in investigat-
ing a biological system once parameters from STAMM have been obtained. The main
contributions to this work are:
⌅ Computational including verifying model selection results for both approaches
(see below), comparison of multiple hyperparameters for Bayesian model selection
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and testing underlying structure of data.
⌅ Comparison where estimated parameters from the model are compared to single-
cell measurement.
5.2 Results from STAMM
5.2.1 Di↵erences in estimation
The initial step before we can make a comparison to single-cell results is to apply STAMM
to the microarray time-course; obtaining single-cell level parameters and the number
of states K. In Armond et al. [2014] there are di↵erences in the estimation pipeline
compared to the one outlined in Section 3.3.3, here we highlight the main di↵erences
during which we try to stay faithful to the notation used in Armond et al. [2014] for ease
of comparison.
The most important idea of a two-step estimation process is shared in both setups.
The first di↵erence is that the optimal number of clusters mˆ is chosen by observing a
plot of the k-means objective function; mˆ is selected when an increase in the number of
clusters does not significantly improve the objective function. The penalty for estimation
used to regularise estimation in eqn. (3.7) is set to a small positive number (in this
application set to   = 0.1). Estimation of transition rates {w} is performed on genes
closest to cluster centroids, instead of the cluster centroids themselves; then transition
rates are fixed and estimation of expression signatures  kj is performed in the same
way. Finally estimation of the number of states Kˆ is approached in two separate ways.
The heuristic approach is to look at two quantities the model fit, i.e. the residual sum-
of-squares (RSS), and the distinctness for individual state signatures quantified by the
condition number C = max(si)/min(si); where si are the singular values of a matrix
made up of the expression signatures. To find the singular values of a matrix A we need
to compute the orthogonal matrices U and V and the matrix D such that A = V DUT ,
where D is a diagonal matrix with its entries corresponding to the singular values. The
other approach for finding an optimum number of states is employed for genes closest
to centroids using ideas from Bayesian model selection. Let y = {yj} denote observed
data and MK the model with K states, we use this notation to distinguish models as
the number of states describes the latent process which is an important distinction in
the mathematical description between models. The posterior probability is P (MK |y) /
p(y|MK) with a flat prior distribution over models. The marginal likelihood p(y|MK)
accounts for the fit-to-data and model complexity. Writing all model parameters as
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✓ = ( kj , {w}, { j}) the marginal likelihood is:
p(y|MK) =
Z
p(y|✓,MK) p(✓|MK)d✓. (5.1)
The marginal likelihood of the model eqn. (5.1) is computed using annealed
importance sampling (AIS) [Neal, 2001]. Hyperparameters for this model are set by
hand to reasonable values, see Supplement of Armond et al. [2014] for details. The
normalised score obtained for the marginal likelihood is the posterior probability for the
number of states.
5.2.2 Estimation results
The primary data used in Armond et al. [2014] is obtained by reprogramming of a
secondary mouse embryonic fibroblast (MEF) where Oct4, Sox2, Klf4, and cMyc are
expressed under induction in the system for 30 days [Samavarchi-Tehrani et al., 2010].
Microarray measurements were made at t = {0, 2, 5, 8, 11, 16, 21, 30} days after induction
of expression factors. The microarray data is standardised per gene such that yj(t) =
(zj(t)  µj) / j , where zj(t) is original log2 transformed data, µj is the mean and  j
is the standard deviation of the time course data for gene j. A total of 4383 genes are
retained out of the whole gene list after filtering out genes with small mean and standard
deviation in their expression over time, as a way of removing uninformative genes. First
we rank genes in order of their mean value and remove genes in the bottom quartile
the remaining set we order by their standard deviation and remove genes in the bottom
quartile of standard deviation.
The number of clusters chosen for this data set of 8 time points is mˆ = 7. As
mentioned above, the penalty used in this application is   = 0.1. With these parameters
set, the transition rates are estimated from cluster representative genes. Once transition
rates are fixed, the expression signatures for the remaining genes are estimated. The
analysis is carried out for K = {2, . . . , 5} and results for model selection are summarised
in Figure 5.1. Unsurprisingly the RSS keeps decreasing for increasing K (Figure 5.2(a))
since numbers of model parameters increase. To determine optimal number of states
heuristically, we compare these results with the condition number (Figure 5.2(b)). We
find that the di↵erence in condition number from K = 4 to K = 5 is larger than the
preceding changes. This suggests that decrease in RSS from 4 to 5 states is mostly due
to overfitting and the additional state is not distinct. The posterior probabilities form
Bayesian model selection for 7 genes closest to the centroid (see above for details), are
shown in Figure 5.2(c). Combined, these results indicate that a Kˆ = 4 since it strikes a
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Figure 5.1: Application of STAMM to a microarray time-course (a) Plot of the model
fit residual sum of squares (RSS). (b) Plot of the condition number for esti-
mated expression signatures quantifying linear dependence between states.
A larger number corresponds to more dependence. (c) Posterior probabili-
ties obtained from Bayesian model selection (see Section 5.2.1 for details).
good balance between model fit and distinct expression signatures for states as well as
having the highest posterior probability.
5.3 Testing against single-cell data
5.3.1 Single-cell experiment
Results in Section 5.2.2 are obtained analysing homogenate time-course data; but the
transformation process itself takes place on a single-cell level therefore obtaining data
single-cell level and studying the behaviour is tremendously valuable. Comparing results
from STAMM to single-cell observations also indicates how well the underlying single-cell
process is modelled. For this purpose we investigate the mRNA single-cell expression
performed by Buganim et al. [2012]. They also investigate a secondary MEF system
reprogrammed by transduction of Oct4, Sox2, Klf4, and cMyc; obtaining data with the
Fluidigm assay, resulting in 96 single-cell measurements with gene expression from 48
genes. Observations are made in populations, starting with MEFs, over cells at 2   6
days during reprogramming, to the final reprogrammed cells.
5.3.2 Comparing results
The single-cell measurements [Buganim et al., 2012] allow for analysis that has not
been possible for population average data. Although important questions about the
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Figure 5.2: Random permutation of time points. The time points of data are randomly
permuted ten times and parameter estimation is carried out for each case.
(a) shows the RSS as a function of the number of states. (b) shows the con-
dition number a measure for the independence of state-specific expression
signatures. In (a) and (b) the solid red line show parameters for the original
data and the dashed line represents the average of ten estimates and the
dashed area represents a standard deviation. (c) shows posterior probabil-
ities as a function of number of states calculated using Bayesian methods
(see Section 5.2.1 for details), results from ten estimations are summarised
as box plots. For both RSS and condition numbers randomised data per-
forms worse for all states. Bayesian model selection for the permuted data
shows no indication that there are intermediate states. The data-set we
use is obtained from [Samavarchi-Tehrani et al., 2010].
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Figure 5.3: Single-cell expression levels in di↵erent experimental settings from
Buganim et al. [2012] are clustering using a standard clustering proce-
dure in R called mclust. We use the Baysian Information Criterion (BIC)
to score di↵erent cluster sizes. We find the optimal number of clusters to
be 3 since the BIC score decreases for larger cluster sizes. This is di↵erent
from the results presented in the paper which suggests 4 states using a less
robust clustering algorithm. This test was performed to check how reliable
the results are using di↵erent methods for clustering.
transformation process such as the number of states and transition rates still remain
di cult to track down (due to the fact that each time a single-cell measurement is made
the cell has to be destroyed and additional work is necessary to determine distinctive
markers for known states for purification) it builds a solid point of comparison for results
estimated using STAMM.
Given available data we can address interesting questions on expression patterns;
since we assume that cells belonging to the same states would have a comparable expres-
sion patterns across observed genes. This is especially the case since measured genes are
deemed important for reprogramming. To this end we cluster the data for all cells in a 48
dimensional gene expression space. To perform the clustering we use a widely available
clustering tool in R mclust; it employs a variety of multi-variate clustering methods
and scores them using the Bayesian Information Criterion (BIC). The best performing
method is shown in Figure 5.3. We find that optimal number of clusters is 3 since the
BIC score starts decreasing for larger cluster sizes. Buganim et al. [2012] suggest four
clusters which they obtain using principle component analysis, which depends heavily
on initial normalisation between samples.
Next, we try to determine if state specific expression signatures, estimated from
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microarray data, can be compared with this new single-cell data. Disregarding conditions
for each cells measurement we assign each of the single-cell measurements to each of the
states in the K = 4 model. Since measurements are performed on di↵erent systems as
well as a using di↵erent procedures we scale pre-processed data to be in the interval
[0, 1] by dividing the expression for a gene by its maximum expression over time. Then
we compute the euclidean distance between gene expression on a single-cell level and
estimated gene expression signatures and assign each cell to a specific state. The heatmap
in Figure 5.4 shows fractions of cells that are assigned to each state. All MEF conditions
have a peak at K = 1. Measurements obtained between t = 2 and t = 44 days are spread
over state K = 1 and K = 3 with very few cells also in the second state. We do not
find any cells, which have measurements close to the final state. Measurements for dox-
independent and iPS cells occupy only the final two states. These results clearly show
a transformation starting with MEF state and undergoing changes across intermediate
states before reaching the final reprogrammed state. Of course, this is a very small study
and studies made on a slightly di↵erent system under di↵erent conditions, therefore even
the approximate similarities we find to our estimated parameters are promising.
5.4 Discussion
We showed how STAMM can be applied to the transformation of di↵erentiated cells from
MEF to iPS cells with the help of reprogramming factors. The data used for the first
part of the analysis was a population averaged microarray time-course. We outlined the
procedure used in Armond et al. [2014] highlighting di↵erences to the estimation pipeline
introduced in Section 3. We present results from fitting STAMM to the data and we
find that a four state model best describes stem-cell reprogramming, which has also been
corroborated by previous experiments [Samavarchi-Tehrani et al., 2010]. Additionally
we showed that data indeed has underlying structure that can be described by STAMM.
To test this we performed estimation for ten samples with randomly permuted time
points and compare RSS scores, condition number and Bayesian model selection. We
found that RSS and condition number are always lower for the original data than the
permuted data. The Bayesian model selection result show a very high concentration at
K = 1 states for the permuted data compared to a high concentration at K = 4 for the
original data. Both results hint that the model is approximating an underlying structure
in the data, as fits with permuted data are systematically worse.
We also compared model predictions from STAMM to the single-cell data, ob-
tained in a di↵erent secondary MEF experiment measuring 48 genes for 96 single-cells
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Figure 5.4: Estimated gene expression signatures using STAMM are compared with
single-cell measurements, performed by Buganim et al. [2012]. Each single-
cell is assigned to a state by finding minimum euclidean distance. The
heatmap summarises the fraction of cells from each experimental condition,
assigned to specific states. Di↵erent conditions show a clear preference for
specific states. Predictions from our model are in line with this observation
where initial MEF states undergo a transformation via intermediate states
to a final reprogrammed state. As an example all MEF populations (top
three entries) have a significantly higher fraction of cells in K = 1. Cells
measured between t = 2 and t = 44 days have cells that spread across the
first and third state, with very few cells occupying the second state. None
of these cells are close to the final state. The two measurements which are
reprogrammed cells (iPS cells and Dox. indep.) show similarities to K = 3
and K = 4, but none of these cells are close to the first two states.
82
[Buganim et al., 2012]. We used a standard clustering tool and determined only 3 states
in the data which can either mean that there is not su cient information available or
that intermediate states are characterised by genes not measured in this experiment. If
we map single-cell measurements at di↵erent time points to gene expression signatures
we find that single-cells measured at di↵erent times are close to the states predicted by
our model at those times. These results are encouraging but for them to be conclusive,
as mentioned above, we would need to carry out further experiments.
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Chapter 6
Cell cycle
6.1 Introduction
In STAMM an important assumption is that the initial cell population is homogeneous.
For the applications we discussed in previous Chapters, this assumption is likely to be
fulfilled as experiments are designed to ensure initial homogeneity. In the case of the
oncogenic transformation, a cell line is used as the initial cell population. In the case of
stem cell reprogramming the technique outlined by Hanna et al. [2009] tries to ensure
initial homogeneity by using a secondary MEF cells.
Recently it has been shown that even seemingly homogeneous cell populations
exist in inherent mixtures, be it at an epigenetic level [Heng et al., 2009; Gerlinger et al.,
2012]. Without knowing the distribution of the initial population it is not possible to
apply STAMM to determine individual states as the solution to the master equation
would be incomplete (see eqn. 3.4 and eqn. 3.5). In this Chapter, we outline a model
that answers the question: What e↵ect does the initial cell population have on cell fate?
An example of such a biological system is one with an initial heterogeneous cell
population made up of two types of cells, with an indistinguishable phenotype. At time
t = 0 the cells receive a stimulus leading to a transformation such that at t = T it is
possible to distinguish cells in their final cell fate. It is possible to count the fraction of
cells that reach each of those final cell fates. The question of interest here is whether the
strength of the stimulus has an e↵ect on the fraction of cells in each cell fate and how cell
fate is related to the expression level of individual genes. A schematic of such a system
is shown in Figure 6.1. As the two cell populations have a di↵erent stimulus response
and we are interested in the influence of gene expression on the response, individual
genes influential in determining cell fate are deemed important if their expression level
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Figure 6.1: Schematic of model. A heterogeneous cell population (the source of het-
erogeneity is unknown) is at rest at t = 0, at which point it is perturbed
by an external stimulus of strength r; evoking a transformation such that
two distinct populations form at a later time t = T . At t = T it is possible
to count the number of cells in di↵erent states.
is significantly di↵erent between cell populations at t = 0.
The idea for this model arose from discussions with the Medema lab at the
NKI and was originally motivated by their interest in cell cycle biology. The possible
experimental application for this model was not ready in time for this thesis therefore
all simulation parameters are merely chosen to ensure a full range of stimulus response
starting from very few cells responding to a weak stimulus, after which the stimulus
is increased until all cells respond and share the same cell fate at t = T . The chosen
parameter might not bear resemblance to their counterparts in a real biological system;
but this model serves as a proof of concept and as long as the basic principles hold, it
can be applied to a real system.
We start this Chapter in Section 6.2 with the basic concepts, introducing variables
and deriving behaviour of such a system followed by the derivation of a model that can
be used to estimate parameters given possible measurements on the system. After that
we set up a simulation procedure in Section 6.3. Finally in Section 6.4 we present results
using simulated data, first with only one gene and then with four genes.
6.2 Formal system description
6.2.1 Setup
Suppose at time t cell i (out of N cells) occupies state X(i)t ; where state here broadly
refers to any aspect of the cell’s physical configuration. This can include protein profile,
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transcription, or its chromatin state. Denote ultimate cell fate at t = T for cell i by Zi.
Cell fate Zi is determined experimentally by enumerating cells in distinguishable states at
t = T . In the simplest case cells can have two distinct final states; we label the two states
Zi = 0 and Zi = 1. We expect the process that determines cell fate to have a stochastic
component such that two cells that appear identical under simple measurements at t = 0
can end up in distinct final states. Hence we assume the probability that cell i is in state
Zi = 1 at t = T depends on two things:
⌅ The physical state of cell i at t = 0, X(i)0 .
⌅ The dose of the stimulus, r.
We assume that the fraction of cells that reach the arrested state changes with
the strength of the stimulus. The fraction of cells that reach cell fate Zi = 1 is dose
dependant and the measured fraction at t = T is denoted by ⇡(r).
6.2.2 Model
First, we will set up the model in a general sense to give a birds-eye view of the system
we are attempting to study. After that, we will derive from this picture the specific
model, which is applicable to data that can be realistically observed. In this Chapter,
focused on concepts, it is important to first outline overall ideas to ensure the actual
model can be fully explained.
We start with formalising the variables. Set the expression of gene j in cell i
measured at time t under stimulus strength r to X(i)jt (r). In the first instance we are
only going to consider one gene therefore we initially drop the subscript j to make the
derivation clearer. When we are referring to measurements at t = 0 they are independent
of the stimulus, therefore we write X(i)0 (r) = X
(i)
0 . The probability of observing a gene
expression conditional on the strength of the stimulus can be written as a combination
of distinct populations present:
p(X(i)t |r) = p(X(i)t , Zi = 1|r) + p(X(i)t , Zi = 0|r) (6.1)
= p(X(i)t |Zi = 1, r) p(Zi = 1|r) + p(X(i)t |Zi = 0, r) p(Zi = 0|r). (6.2)
Now the expected value for the expression, conditional on the strength of the stimulus,
can be calculated using the results of eqn. (6.2) as:
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E[X(i)t |r] =
Z
X(i)t p(X
(i)
t |r)dX(i)t (6.3)
= p(Zi = 1|r)
Z
X(i)t p(X
(i)
t |Zi = 1, r)dX(i)t +
+ p(Zi = 0|r)
Z
X(i)t p(X
(i)
t |Zi = 0, r)dX(i)t .
(6.4)
Introducing the new variable ⇡(r) = p(Zi = 1|r), and for a two state system naturally
1  ⇡(r) = p(Zi = 0|r) we rewrite eqn. (6.4)
E[X(i)t |r] = ⇡(r) E[X(i)t |Zi = 1, r] + (1  ⇡(r)) E[X(i)t |Zi = 0, r]. (6.5)
To simplify the notation and write a general equation for a system of this type we rewrite
the expected value of the gene expression level for cells in state Zi = 1 and Zi = 0 as
↵(r) = E[X(i)t |Zi = 1, r] and  (r) = E[X(i)t |Zi = 0, r] respectively and write:
E[X(i)t |r] = ⇡(r)↵(r) + (1  ⇡(r))  (r). (6.6)
In the biological system described above gene expression is measured at t = 0 and is
independent of the applied stimulus since it is only applied at the initial time point.
Therefore we define the expected value of measured expression reintroducing gene j,
E[X(i)t=0|r] = X0, as:
X0j = ⇡(r)↵j(r) + (1  ⇡(r))  j(r). (6.7)
The system is now fully described, potential measurements that can be made here
are the average expression levels of genes at t = 0, X0j and the fraction of cells in state
Z = 1 at time t = T . On account of the lack of information about the variables ↵(r) and
 (r) or their distribution, estimation using eqn. (6.7) is not feasible. Therefore, below
we formulate a procedure to estimate parameters that would allow us to determine genes
that significantly influence the transition between states under a stimulus.
Estimation
We start by defining the fraction of cells in state Zi = 1 at t = T , note that the
derivation in the following few lines is equivalent for cells where Zi = 0. We will perform
the detailed calculation for only one case. Here it is also easier to use X0 as a vector
notation for X0j
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⇡(r) ⌘ p(Zi = 1|r) =
Z
p(Zi = 1|X0, r)p(X0|r)dX0 (6.8)
=
Z
f(X0; r, ✓)p(X0|r)dX0, (6.9)
where in eqn. (6.9) we have replaced p(Zi = 1|X0, r) by a general parametric function
of the gene expression dependent on the stimulus and a set of parameters ✓, f(X0; r, ✓).
Since p(X0|r) is the probability distribution of gene expression at time t = 0 over all
cells a good approximation to this process is the exponential distribution as genes are
expressed continuously independently from each other at a constant rate. The parameter
 j of the exponential distribution can be set to the measured gene expression for gene j
at t = 0 and will be di↵erent for every gene. Therefore we can rewrite eqn. (6.9) as:
p(Zi = 1|r) = E[f(X0; r, ✓)]Exp( j). (6.10)
The expression in eqn. (6.10) is general and allows for an expression depending on the
problem being investigated. Obtaining a closed form solution of the expectation value
is only possible for special cases. For the biological system we present below there is
no closed form solution. Hence, we propose a numerical approximation using a Monte
Carlo integration. We can therefore write:
⇡(r) ⇡ 1
N
NX
n=1
f(X(n)0 ; r, ✓), (6.11)
where each component of the vector X(n)0 is sampled from the exponential distribution.
In each case, it has to be considered if a simple application is su cient, or if there is
need for a more involved algorithm. To identify the optimal set of parameters in the
estimation we perform a grid search over all parameters and compare the residual sum
of squares (RSS) between observation and estimation using eqn. (6.11).
Application to the cell cycle
A biological system where the model described above could be applied to is cell cycle
arrest due to radiation. The system is quite simple a population of cells is exposed to
varying levels of radiation starting at t = 0. The expression level of these cells is measured
using RNA-Seq. At a later time t = 2h cells reach two possible states: (i) arrest leading
to cell death, or (ii) the cell still has the ability to enter cell cycle and replicate. The
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fraction of cells in either state can be counted at t = 2h. In this application, increasing
the dose of radiation of course decreases the number of cells that can re-enter the cell
cycle. It is of interest to distinguish discriminatory factors for both cells that determine
ultimate fate of a cell.
In this application we have a few simple relationships that our choice of f(X(n)0 ; r, ✓)
has to obey. Below a certain radiation threshold the e↵ect of radiation will be negli-
gible, and above a certain radiation threshold almost all cells will arrest. Under such
constraints, the best choice is a sigmoid of the form:
f(X(n)0 ; r, ✓) =
1
1 + exp( r aTX(n)0 + b)
, (6.12)
where a and b are parameters of the sigmoid to be determined from estimation. A large
negative or positive value in a for a gene means it has a larger influence on transforma-
tion.
6.3 Simulation
The simulation setup we choose for this model is based on a single-cell level approach
which we employ in Section 3.4 obtaining very useful results. The first step is to simulate
gene expression for each gene and a fixed number of cells; this is sampled from an
exponential distribution for each gene Exp( j). Then the probability of being in state
Zi = 1 is determined using eqn. (6.12) based on expression levels of all genes involved
and fixed radiation value and parameters a and b. Drawing a value uniformly at random
in the range [0, 1] determines for each cell if it is in the arrest state. Using this final
state vector we can determine ⇡(r). Measurements for such a system will be limited
so we repeat these simulation steps for only 9 values of r. Since in a real experiment
measurements of fraction of cells will be noisy, we add Gaussian noise to the fraction of
cells observed with zero mean N (0, ), .
6.4 Results
6.4.1 Single gene simulation
Initially we perform the simulation and estimation with only a single gene. This is to
determine whether or not it is possible to estimate parameters for the simplest possible
case. We perform simulations for 1000 cells for one gene with Exp( j = 5) at r =
{0, 0.1, 0.5, 1, 2, 3, 5, 6, 10}. The sigmoid parameters are chosen as a = 2 and b = 5. To
89
Figure 6.2: Single cell simulation for one gene. Plots show the states of cells at di↵erent
expression levels after exposure to radiation r for t = 2h. Each figure
represents a di↵erent dose of radiation r. The y-axis shows expression
level and the x-axis is just an index over 2000 cells which are used in the
simulation. State Zi = 0 is the normal state of the cell and state Zi = 1 is
when cells enter the arrest state.
visualise the single cell simulation behaviour Figure 6.2 shows the states occupied at
t = 2h by 1000 cells at di↵erent radiation doses. The y-axis in the plot represents gene
expression transformed for convenience to arcsinh(X0). Once we have obtained values
for ⇡(r) from this setup we add two levels of Gaussian noise   = {0.025, 0.05, 0.1}. Since
the measured quantity is in the range [0, 1] this is a reasonable level of noise, ranging
from 2.5% to 10% of the simulated trajectory. Finally we choose a grid for b over the
interval [0, 10] and a over the interval [0, 4] and find the minimal RSS. The results from
these estimations are summarised in Table 6.1. We see that for   = 0.025 the estimates
are very close to the true values used in simulation. At higher noise, the estimates
become progressively worse, but the parameter order is still preserved.
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true value   = 0.025   = 0.05   = 0.1
a 2 1.655 1.124 0.828
b 5 4.483 3.448 2.759
Table 6.1: Estimation of a and b parameters from simulated data. Data is obtained by
adding Gaussian noise to the simulated trajectory with di↵erent   values.
6.4.2 Simulation with multiple genes
Just performing simulation using a single gene only serves to show the simulation pipeline
and as a first test to determine if the model will work. If we wish to determine how
well the proposed model will serve in a realistic application it is necessary to expand
the simulation to include multiple genes, otherwise the model is not useful. To this end
we implement a simulation with 4 genes. Just like above we perform a simulation with
1000 genes measured at r = {0, 0.1, 0.5, 1, 2, 3, 5, 6, 10}. We choose the parameters as
follows b = 5 and a = [1, 5, 10, 0.2] and the mean gene expression for each gene is drawn
uniformly between [0, 20]. To estimate parameters we apply a grid over all parameters
calculating the integral eqn. (6.11) with the Monte carlo approximation and find the
parameter set that minimises RSS. This is of course a very ine cient method, and with
increase in parameters, the grid search quickly becomes unfeasible. A more sophisticated
implementation of parameter selection is necessary for a realistic application. We repeat
this simulation 10 times with independently drawn over expression and we repeat this
for two di↵erent standard deviations of noise added to the fraction of transformed cells
0.05 and 0.1. Figure 6.3 shows the results for both noise levels and we can see that for
lower noise the estimation works well and parameters are estimated in the right order.
For larger noise, this is already di cult and some parameters are estimated well and
some are not.
6.5 Discussion
We derived the model starting from general biological principles including a description
of the system. We introduced one possible application for this model in a radiated cell
population either stopping cells in cell cycle or only temporarily halting the cell cycle. In
such an experiment, we wanted to find the importance of genes for the transformation.
In this model, there is one parameter that determines the importance of genes. The
higher the value for a gene the more important that gene is in transformation. We
showed in simulation that we can obtain parameters even when we add large amounts
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Figure 6.3: Simulation study. Ten simulations carried out with four genes. The ex-
pression for genes in each cell are sampled from an exponential distri-
bution with the mean chosen uniformly between [0, 20], stimuli used at
r = {0, 0.1, 0.5, 1, 2, 3, 5, 6, 10}. Parameters for the simulation is chosen as
b = 5 and a = [1, 5, 10, 0.2] for the simulation. (a) is the simulations with
Gaussian noise added at   = 0.05. The estimated parameters are ranked in
the correct order. (b) is the simulation performed where additive Gaussian
noise has   = 0.1. Here parameter estimation is worse, but not unexpected
since the noise added is at 10% of the observed data values.
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of noise to the simulated data in a single gene scenario. With limited observations made
on the system (the initial gene expression and proportions of cells reaching a specific cell
fate for di↵erent stimuli) we are interested in finding out if the level of expression of a
gene influences cell fate. It will not be possible to estimate exact parameter values. We
show that it is possible to obtain ranks of genes using this model.
For a real application, further work is needed. Only with real data comparison
is it possible to determine if the choices made for parameters during simulation are
reasonable and if simulated state fractions are realistic. Further work is also needed to
implement a more useful parameter search instead of the crude one implemented at the
moment. Once it can be compared to data, it will also be possible to refine the model if
needed.
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Chapter 7
Discussion and Outlook
Advancements in measuring population level transcription, proteomic abundance and
epigenetic information cheaply, has led to widespread application of these methods.
Additionally, techniques for measurements on a single-cell level have also been developed
in more recent years [Wheeler et al., 2003; Dalerba et al., 2011; Wang & Bodovitz,
2010], but these techniques have their own shortcomings.They su↵er from a limitation
on the amount of information (e.g. number of genes that can be measured) that can
be obtained. For transforming biological systems, single-cell measurements would be
ideal even if there is a limit on the amount of information available. However, current
techniques require destruction of cells for a measurement of more than a handful of genes
or proteins. Therefore, techniques that attempt to deconvolve information on the single-
cell level from population level data are extremely important for a better understanding
of causes and triggers of transformation.
Chapter 3 is focused on state transitions, using aggregated Markov models (STAMM)
where we expanded on previous work [Armond et al., 2014] and presented a full descrip-
tion of the model including assumptions. We investigated properties of the model such
as (empirical) identifiability, behaviour when assumptions are broken using single-cell
simulations and proposed a computationally e cient unbiased approach to parameter
estimation and model selection. We showed empirically that the model is identifiable
given that assumptions hold. Under breaking model assumptions, estimations are stable.
However, if model assumptions are strongly violated estimations for transition rates can
be badly estimated despite good estimation of state specific expression. Therefore, all
estimation results should be experimentally verified. Alternatively, estimation results
can be used to determine further directions or research.
In Chapter 4 we applied STAMM to RNA-seq data obtained by in vitro experi-
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ments for oncogenic transformation of a MCF-10A cell line. The system is based on one
of the most well studied oncogenes, but there remain open questions about exact steps
required for the transformation. Due to a mycoplasm infection in the cells used for the
in vitro study, biological conclusions need to be interpreted with caution. Therefore, this
application is useful to illustrate that STAMM can be applied to RNA-seq data with
useful results but biological conclusions require further work. In future, this oncogenic
transformation, due to its rapid transformation and relatively clean induction, can be
used to validate the model in more detail and will also enable the extension of the model.
Finding unique surface marker combinations for individual states it will be possible to
identify those. The next step would be the isolation of single cells, utilising a technique
based on identified surface markers, after which estimated parameters can be verified.
We also showed that this implementation of the model is computationally e cient and
it takes less than 4 hours to estimate p = 2809 genes on fifty cores.
Chapter 5 contains a concise outline of application of STAMM to a microarray
time-course obtained from reprogramming di↵erentiated cells to iPS cells. We briefly
sketched the procedure used in Armond et al. [2014] and parameters obtained during
estimation. To test if estimation results are accidental or if data indeed has underlying
structure, we also applied STAMM to randomly permuted data. Results show that
there was indeed structure in the data that is modelled by the latent Markov chain.
Then we compare model predictions from STAMM to recent single-cell data from a
di↵erent secondary MEF experiment [Buganim et al., 2012]. We determine that results
are consistent with findings from single-cell measurements in terms of the number of
intermediate states. Single-cells measured at di↵erent time points can be mapped well
to corresponding state specific expression signatures.
We note that though we restrict our investigation to applications of STAMM to
gene expression data, this is just a consequence of the systems being investigated. The
model itself can be applied to any type of data that is considered to be relevant to a
transformation process. The future development of this model could include incorpora-
tion of additional experiments. For instance, once parameters have been estimated from
data, a second round of experiments could verify transition rates by filtering out cells
in a state and determining transition to the next state for those cells. Once transition
rates are fixed, estimation of expression signatures becomes more accurate as well. In
fact, once transition rates and number of states have been experimentally verified the
model could be extended to also probe single state dynamics.
In Chapter 6 we proposed a model for an initially heterogeneous population where
it is possible to observe ultimate cell-fate subject to a stimulus. The gene expression is
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only measured for the initial cell population and subsequent cell-fate is determined for
di↵erent stimulus strengths. Starting from basic principles, we set out a description of
the biological system followed by an outline of the estimation procedure based on data
obtained experimentally. We set out a single-cell simulation procedure for this system.
We use a single gene simulation and a four gene simulation to test the model. We show
in single gene simulations, that it is possible to pick out parameters at a variety of noise
levels. In the four gene, simulation parameters are picked out well at low noise levels.
At higher noise levels, this is more problematic and some parameters are not estimated
well.
Transformation processes in biology are central to understanding many diseases
and potential developments of cures. Therefore, it is important that their study is
actively pursued. Due to single-cell stochasticity, many studies concentrate on final and
initial states of cells because intermediate stages of transformation are more di cult
to probe. The types of models we outline in this thesis could prove invaluable for
a full understanding of transformation processes. Modern genome-wide experimental
techniques that take measurements for single-cells still destroy the cells, thus still only
giving a snapshot in time [de Souza, 2012]. These measurements in conjunction with
STAMM would allow for a powerful reconstruction of the transformation process. It is
clear, there still remains a lot of work to be done to understand cellular transformations
in biology and we believe that models that take the single-cell level stochasticity into
account could provide crucial assistance in this endeavour.
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Additional results STAMM
● ●●
●
● ●
●
●
●
● ● ●
●●●
● ● ● ●●
● ●●●
●
● ● ● ●●
●
●●
●●
● ● ● ●●
● ●●●● ● ● ● ●●
●
●●
●● ●
●
●
●●
●
●●
●●
●
● ● ●●
● ●●●
● ●
● ●
●●
● ●
●●●
●
● ● ●
●
● ●●●● ● ● ● ●●
0.002 0.003 0.004 0.005
0.006 0.01 0.03 0.05
0.07 0.09
0.00
0.25
0.50
0.75
1.00
0.00
0.25
0.50
0.75
1.00
0.00
0.25
0.50
0.75
1.00
0.01 0.10 0.01 0.10death rate
ρ(
β,
β)
 
(a) expression signatures
Figure A.1: Figure carried on below.
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Figure A.1: Simulation study. This plots extends Figure 3.8 to include addition values
for the doubling rate, plots are divided into panels for each cell doubling
rate. Simulations are independently repeated 10 times. (a) shows corre-
lation between true and estimated  kj as a function of death rates. (a)
shows di↵erence between estimated occupation probabilities and true val-
ues (see Section 3.5.1). In (a) and (a) show the mean as a solid line and the
shaded area represents the standard deviation. (b) - (d) shows box plots
for estimated transition rates with the dashed line showing true values.
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Figure A.2: Simulation study. To highlight the e↵ect of badly estimated transition
rates we show state occupation probabilities for each state. The solid
line shows probabilities for transition rates [0.2, 0.1, 0.05] the dashed line
shows occupation probabilities with transition rates [0.4, 0.2, 0.1]. This
shows that estimating transition rates is a more di cult problem; as even
large deviations in transition rates lead to only small changes in occupation
probability which is the only way transition rates enter the estimation. An
even though the di↵erence is significant overall it has a small e↵ect as the
expression signatures are much larger.
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Appendix B
RNA-seq pre-processing
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Figure B.1: To determine sequencing depth from RNA-seq experiments we pre-process
data using the edgeR package. See package Robinson et al. [2010] for
details of exact usage which briefly outlined in Section 2.3.2. We propose
a strategy of trimming the log ratio eqn. (2.18) at di↵erent values and
identifying the cuto↵ that stabilises sequencing depths for the di↵erent
samples. For this example we chose 0.4.
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0hr 0.5hr 1hr 2hr 4hr 6hr 8hr
MFGE8 62.35 47.88 63.05 53.02 46.26 35.66 46.50
MFGE8 raw count 916.00 874.00 1046.00 774.00 708.00 496.00 654.00
CCDC99 64.19 78.61 65.76 67.81 78.86 78.23 59.65
CCDC99 raw count 943.00 1435.00 1091.00 990.00 1207.00 1088.00 839.00
TAB2 96.59 117.40 105.66 98.64 91.80 95.85 108.64
TAB2 raw count 1419.00 2143.00 1753.00 1440.00 1405.00 1333.00 1528.00
ZSWIM6 19.13 19.12 18.93 20.07 16.66 21.79 24.25
ZSWIM6 raw count 281.00 349.00 314.00 293.00 255.00 303.00 341.00
FLRT3 18.18 22.95 17.42 14.86 24.18 47.53 53.47
FLRT3 raw count 267.00 419.00 289.00 217.00 370.00 661.00 752.00
HTRA1 231.45 211.19 193.78 205.63 207.32 166.74 159.48
HTRA1 raw count 3400.00 3855.00 3215.00 3002.00 3173.00 2319.00 2243.00
NCOA4 232.13 238.91 171.78 238.10 268.28 261.94 214.94
NCOA4 raw count 3410.00 4361.00 2850.00 3476.00 4106.00 3643.00 3023.00
TGIF1 39.75 42.51 47.68 40.55 41.29 50.40 47.21
TGIF1 raw count 584.00 776.00 791.00 592.00 632.00 701.00 664.00
IL1RAP 94.48 90.83 81.37 90.76 153.22 416.82 422.42
IL1RAP raw count 1388.00 1658.00 1350.00 1325.00 2345.00 5797.00 5941.00
CSRNP1 19.20 17.37 37.55 84.80 16.14 40.48 53.04
CSRNP1 raw count 282.00 317.00 623.00 1238.00 247.00 563.00 746.00
SEPT9 337.84 352.21 392.74 348.45 359.88 572.56 647.45
SEPT9 raw count 4963.00 6429.00 6516.00 5087.00 5508.00 7963.00 9106.00
SF3A3 133.83 155.20 113.37 133.43 146.49 148.48 136.66
SF3A3 raw count 1966.00 2833.00 1881.00 1948.00 2242.00 2065.00 1922.00
ESR1 1184.12 1258.93 2332.92 1103.56 845.35 470.68 618.94
ESR1 raw count 17395.00 22980.00 38706.00 16111.00 12938.00 6546.00 8705.00
C1orf43 382.43 383.05 282.08 368.72 344.20 306.09 299.69
C1orf43 raw count 5618.00 6992.00 4680.00 5383.00 5268.00 4257.00 4215.00
STMN1 365.96 368.80 279.54 336.12 329.89 290.49 249.28
STMN1 raw count 5376.00 6732.00 4638.00 4907.00 5049.00 4040.00 3506.00
PFDN5 153.57 116.20 91.80 103.84 116.69 110.37 104.09
PFDN5 raw count 2256.00 2121.00 1523.00 1516.00 1786.00 1535.00 1464.00
LDHB 1280.10 1252.25 913.31 1167.27 1225.75 1222.57 1129.88
LDHB raw count 18805.00 22858.00 15153.00 17041.00 18760.00 17003.00 15891.00
XPO6 169.98 187.91 205.65 182.34 172.10 216.50 218.50
XPO6 raw count 2497.00 3430.00 3412.00 2662.00 2634.00 3011.00 3073.00
RPS25 402.65 299.45 228.43 279.13 287.16 282.79 269.83
RPS25 raw count 5915.00 5466.00 3790.00 4075.00 4395.00 3933.00 3795.00
DYSF 2.04 2.08 1.27 1.16 1.05 1.87 3.06
DYSF raw count 30.00 38.00 21.00 17.00 16.00 26.00 43.00
Table B.1: The table shows a very small sample of data used in Chapter 4 and we show
the e↵ect on the data due to normalisation, see Section 2.3.2 for details of the
normalisation. The white rows show data after normalisation and the blue rows
the corresponding raw counts obtained from RNA-seq
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